<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Interventions for managing oral submucous fibrosis - Jones, A - 2024 | Cochrane Library</title> <meta content="Interventions for managing oral submucous fibrosis - Jones, A - 2024 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007156.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Interventions for managing oral submucous fibrosis - Jones, A - 2024 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007156.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD007156.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Interventions for managing oral submucous fibrosis" name="citation_title"/> <meta content="Adam Jones" name="citation_author"/> <meta content="School of Dentistry, Faculty of Medicine and Health, University of Leeds" name="citation_author_institution"/> <meta content="adam.jones7@nhs.net" name="citation_author_email"/> <meta content="Benjamin Veale" name="citation_author"/> <meta content="Airedale General Hospital" name="citation_author_institution"/> <meta content="Tiffany Li" name="citation_author"/> <meta content="Leeds Teaching Hospitals" name="citation_author_institution"/> <meta content="Vishal R Aggarwal" name="citation_author"/> <meta content="University of Leeds" name="citation_author_institution"/> <meta content="Joshua Twigg" name="citation_author"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="2" name="citation_issue"/> <meta content="10.1002/14651858.CD007156.pub3" name="citation_doi"/> <meta content="2024" name="citation_date"/> <meta content="2024/02/28" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007156.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007156.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD007156.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Abdominal Pain; Antioxidants; Dexamethasone; *Drug-Related Side Effects and Adverse Reactions; *Oral Submucous Fibrosis [therapy]; *Pentoxifylline; Vasodilator Agents" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD007156.pub3&amp;doi=10.1002/14651858.CD007156.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="qy4lqFNF";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD007156\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD007156\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","hi","zh_HANT","th","ko","ms","ja","fa","fr","pl"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD007156.pub3",title:"Interventions for managing oral submucous fibrosis",firstPublishedDate:"Feb 28, 2024 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Oral Health Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=qy4lqFNF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007156.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007156.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD007156.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD007156.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007156.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD007156.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;hi&quot;,&quot;title&quot;:&quot;सारांश&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hi&quot;,&quot;title&quot;:&quot;सरल भाषा संक्षेप&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD007156.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD007156.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD007156.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD007156.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>905 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD007156.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-sec-0138"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-sec-0014"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-sec-0015"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-sec-0039"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-sec-0132"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/appendices#CD007156-sec-0143"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/supinfo/CD007156-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/supinfo/CD007156-dataPackage.zip?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2024 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> <li aria-label="There has been an important change to the conclusions of the review." class="status-item up-to-date custom-tooltip" data-status="conclusionchanged" title="There has been an important change to the conclusions of the review."> <a class="btn secondary" href="information#history">Conclusions changed</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Interventions for managing oral submucous fibrosis</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information#CD007156-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Adam Jones</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information#CD007156-cr-0005">Benjamin Veale</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information#CD007156-cr-0006">Tiffany Li</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information#CD007156-cr-0007">Vishal R Aggarwal</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information#CD007156-cr-0008">Joshua Twigg</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information/en#CD007156-sec-0154">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 28 February 2024 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD007156.pub3">https://doi.org/10.1002/14651858.CD007156.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD007156-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007156-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007156-abs-0019">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007156-abs-0014">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007156-abs-0016">Français</a> </li> <li class="section-language"> <a class="" href="full/hi#CD007156-abs-0005">हिंदी</a> </li> <li class="section-language"> <a class="" href="full/ko#CD007156-abs-0010">한국어</a> </li> <li class="section-language"> <a class="" href="full/th#CD007156-abs-0008">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007156-abs-0003">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD007156-abs-0001" lang="en"> <section id="CD007156-sec-0001"> <h3 class="title" id="CD007156-sec-0001">Background</h3> <p>Oral submucous fibrosis (OSF) is a chronic disease of the oral cavity that causes progressive constriction of the cheeks and mouth accompanied by severe pain and reduced mouth opening. OSF has a significant impact on eating and swallowing, affecting quality of life. There is an increased risk of oral malignancy in people with OSF. The main risk factor for OSF is areca nut chewing, and the mainstay of treatment has been behavioural interventions to support habit cessation. This review is an update of a version last published in 2008. </p> </section> <section id="CD007156-sec-0002"> <h3 class="title" id="CD007156-sec-0002">Objectives</h3> <p>To evaluate the benefits and harms of interventions for the management of oral submucous fibrosis. </p> </section> <section id="CD007156-sec-0003"> <h3 class="title" id="CD007156-sec-0003">Search methods</h3> <p>We used standard, extensive Cochrane search methods. The latest search date was 5 September 2022. </p> </section> <section id="CD007156-sec-0004"> <h3 class="title" id="CD007156-sec-0004">Selection criteria</h3> <p>We considered randomised controlled trials (RCTs) of adults with a biopsy‐confirmed diagnosis of OSF treated with systemic, locally delivered or topical drugs at any dosage, duration or delivery method compared against placebo or each other. We considered surgical procedures compared against other treatments or no active intervention. We also considered other interventions such as physiotherapy, ultrasound or alternative therapies. </p> </section> <section id="CD007156-sec-0005"> <h3 class="title" id="CD007156-sec-0005">Data collection and analysis</h3> <p>We used standard Cochrane methods. Our primary outcomes were 1. participant‐reported resumption of normal eating, chewing and speech; 2. change or improvement in maximal mouth opening (interincisal distance); 3. improvement in range of jaw movement; 4. change in severity of oral/mucosal burning pain/sensation; 5. adverse effects. Our secondary outcomes were 6. quality of life; 7. postoperative discomfort or pain as a result of the intervention; 8. participant satisfaction; 9. hospital admission; 10. direct costs of medication, hospital bed days and any associated inpatient costs for the surgical interventions. We used GRADE to assess certainty of evidence for each outcome. </p> </section> <section id="CD007156-sec-0006"> <h3 class="title" id="CD007156-sec-0006">Main results</h3> <p>We included 30 RCTs (2176 participants) in this updated review. We assessed one study at low risk of bias, five studies at unclear risk of bias and 24 studies at high risk of bias. </p> <p>We found diverse interventions, which we categorised according to putative mechanism of action. We present below our main findings for the comparison 'any intervention compared with placebo or no active treatment' (though most trials included habit cessation for all participants). Results for head‐to‐head comparisons of active interventions are presented in full in the main review. </p> <p><b><i>Any intervention versus placebo or no active treatment</i> </b> </p> <p><b>Participant‐reported resumption of normal eating, chewing and speech</b> </p> <p>No studies reported this outcome.</p> <p><b>Interincisal distance</b> </p> <p>Antioxidants may increase mouth opening (indicated by interincisal distance (mm)) when measured at less than three months (mean difference (MD) 3.11 mm, 95% confidence interval (CI) 0.46 to 5.77; 2 studies, 520 participants; low‐certainty evidence), and probably increase mouth opening slightly at three to six months (MD 8.83 mm, 95% CI 8.22 to 9.45; 3 studies, 620 participants; moderate‐certainty evidence). Antioxidants may make no difference to interincisal distance at six‐month follow‐up or greater (MD −1.41 mm, 95% CI −5.74 to 2.92; 1 study, 90 participants; low‐certainty evidence). </p> <p>Pentoxifylline may increase mouth opening slightly (MD 1.80 mm, 95% CI 1.02 to 2.58; 1 study, 106 participants; low‐certainty evidence). </p> <p>However, it should be noted that these results are all less than 10 mm, which could be considered the minimal change that is meaningful to someone with oral submucous fibrosis. </p> <p>The evidence was very uncertain for all other interventions compared to placebo or no active treatment (intralesional dexamethasone injections, pentoxifylline, hydrocortisone plus hyaluronidase, physiotherapy). </p> <p><b>Burning sensation</b> </p> <p>Antioxidants probably reduce burning sensation visual analogue scale (VAS) scores at less than three months (MD −30.92 mm, 95% CI −31.57 to −30.27; 1 study, 400 participants; moderate‐certainty evidence), at three to six months (MD −70.82 mm, 95% CI −94.39 to −47.25; 2 studies, 500 participants; moderate‐certainty evidence) and at more than six months (MD −27.60 mm, 95% CI −36.21 to −18.99; 1 study, 90 participants; moderate‐certainty evidence). </p> <p>The evidence was very uncertain for the other interventions that were compared to placebo and measured burning sensation (intralesional dexamethasone, vasodilators). </p> <p><b>Adverse effects</b> </p> <p>Fifteen studies reported adverse effects as an outcome. Six of these studies found no adverse effects. One study evaluating abdominal dermal fat graft reported serious adverse effects resulting in prolonged hospital stay for 3/30 participants. There were mild and transient general adverse effects to systemic drugs, such as dyspepsia, abdominal pain and bloating, gastritis and nausea, in studies evaluating vasodilators and antioxidants in particular. </p> </section> <section id="CD007156-sec-0007"> <h3 class="title" id="CD007156-sec-0007">Authors' conclusions</h3> <p>We found moderate‐certainty evidence that antioxidants administered systemically probably improve mouth opening slightly at three to six months and improve burning sensation VAS scores up to and beyond six months. We found only low/very low‐certainty evidence for all other comparisons and outcomes. There was insufficient evidence to make an informed judgement about potential adverse effects associated with any of these treatments. There was insufficient evidence to support or refute the effectiveness of the other interventions tested. </p> <p>High‐quality, adequately powered intervention trials with a low risk of bias that compare biologically plausible treatments for OSF are needed. It is important that relevant participant‐reported outcomes are evaluated. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD007156-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD007156-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD007156-abs-0020">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD007156-abs-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD007156-abs-0017">Français</a> </li> <li class="section-language"> <a class="" href="full/hi#CD007156-abs-0006">हिंदी</a> </li> <li class="section-language"> <a class="" href="full/ja#CD007156-abs-0013">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD007156-abs-0011">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD007156-abs-0012">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD007156-abs-0018">Polski</a> </li> <li class="section-language"> <a class="" href="full/th#CD007156-abs-0009">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD007156-abs-0004">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD007156-abs-0007">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD007156-abs-0002" lang="en"> <h3>Interventions for the management of oral submucous fibrosis</h3> <p><b>Review question</b> </p> <p>Which treatments are effective in improving the symptoms associated with oral submucous fibrosis? </p> <p><b>Key messages</b> </p> <p>– The overall results are mixed but indicate that using antioxidant medications may be useful to treat restricted mouth opening and are likely to improve the burning sensation in the mouth that is experienced by people who have oral submucous fibrosis. </p> <p><b>What is oral submucous fibrosis?</b> </p> <p>Oral submucous fibrosis is a disease that causes increasing tightness of the cheeks and mouth. People with this condition often have persistent burning mouth pain. These problems can make eating, speaking and swallowing more difficult. Many medicines have been suggested to manage this condition and may be taken by mouth (systemically), applied locally to the surface (topically) or injected directly into the affected areas. Different forms of surgery or physiotherapy are also available. </p> <p><b>What did we want to know?</b> </p> <p>We wanted to find out which treatments are effective for improving the symptoms of oral submucous fibrosis, and which treatments are the most effective. We also wanted to know what the risks and side effects of each treatment might be and how common these are. </p> <p><b>What did we do?</b> </p> <p>We searched databases of medical and dental journals and research trials. We only selected trials known as randomised controlled trials. In this type of trial, participants are allocated to groups randomly. One group receives the intervention and the other receives a different treatment or no treatment at all. These trials aim to reduce the risk of introducing bias in clinical trials. </p> <p>We wanted to focus on how well treatments worked to allow people with oral submucous fibrosis to return to normal eating, chewing and speaking. Because no trials looked at these measures, we chose increase in mouth opening (measured in millimetres between the upper and lower front teeth) and reduction oral burning sensation (measured on a scale from 0 to 100) as the most likely measures to improve quality of life in people with oral submucous fibrosis. We looked for details of these measures immediately after treatment (up to three months), in the medium term (three to six months) and in the longer term (after six months). We also looked for information on any 'adverse effects' (negative side effects of the treatments). </p> <p><b>What did we find?</b> </p> <p>We found 30 relevant trials. Most trials looked at different treatments that each worked differently. Many trials compared different types of treatments with each other. We decided that trials comparing one treatment against no active treatment were most important because we do not know which, if any, treatments actually work. </p> <p>The results told us that antioxidant medicines (which scavenge and neutralise unstable particles that are naturally formed during metabolism or by exposure to environmental toxins) taken by mouth may improve mouth opening slightly for up to six months after treatment, but we are not sure that this lasts longer than six months. Antioxidants may also reduce burning sensation in the mouth for more than six months after treatment and we think this might be an important improvement for people with oral submucous fibrosis. </p> <p>The evidence for other treatments that we looked at was very uncertain.</p> <p>Only half of the trials reported side effects or other potentially harmful effects of the treatments, so it is difficult to say confidently how safe any of the treatments might be. </p> <p><b>What are the limitations of the evidence?</b> </p> <p>We are moderately confident that antioxidants help in the treatment of oral submucous fibrosis, but have little confidence in the other evidence because many trials had design limitations. </p> <p><b>How up to date is the search?</b> </p> <p>We searched for trials up to 5 September 2022.</p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD007156-sec-0138" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD007156-sec-0138"></div> <h3 class="title" id="CD007156-sec-0139">Implications for practice</h3> <section id="CD007156-sec-0139"> <p>Based on the quality of the available evidence and wide range of interventions evaluated, with multiple potential biological mechanisms of action, it is difficult to draw any firm conclusions about treatment of oral submucous fibrosis (OSF). Any treatment provided should be preceded by carefully evaluating the potential risks and benefits, with highly invasive treatments such as surgical intervention, which carry a high risk of morbidity, only used with clear justification on an individual case basis. </p> <p>Within the above limitations, we found moderate‐certainty evidence that antioxidants administered systemically probably improve mouth opening slightly at three to six months and improve burning sensation VAS scores up to and beyond six months. The clinical importance of the improvements in mouth opening are unclear; the improvements in burning sensation may be clinically important based on findings from chronic pain literature. We found only low/very low‐certainty evidence for all other comparisons and outcomes. There was insufficient evidence to make an informed judgement about potential adverse effects associated with any of these treatments. There was insufficient evidence to support or refute the effectiveness of the other interventions tested. </p> <p>Based on the findings, antioxidant supplements show promise in the management of OSF. However, prescribers should be cautious and consider potential drug interactions and ensure patients understand dose recommendations, as many supplements are available without prescription. It is also important for clinicians to report any adverse events – expected or unexpected – that may be associated with antioxidant use, such as by using the UK Medicines and Healthcare products Regulatory Agency's (MHRA) 'Yellow Card' scheme. Except for the effect of antioxidants on burning sensation, there was insufficient evidence to determine the effectiveness of interventions for longer than six months. Given the lack of evidence around effective treatments, the mainstay approach to OSF will continue to be prevention using behavioural interventions to support habit cessation<i>.</i> </p> </section> <h3 class="title" id="CD007156-sec-0140">Implications for research</h3> <section id="CD007156-sec-0140"> <p>High‐quality intervention trials with a low risk of bias that compare treatments for OSF against non‐active controls are needed. Future trials should be conducted and reported according to the CONSORT statement (<a href="http://www.consort-statement.org/" target="_blank">www.consort-statement.org/</a>), and focus on biologically plausible interventions with a proposed mechanism of action identified and tested from studies conducted in vitro or using animal models. In addition, future trials should standardise research methods, in particular focusing on patient‐reported outcomes and standardising assessment of other outcomes such as interincisal distance and burning sensation. It would be useful to establish agreed minimum clinically important differences for key outcomes. Investment in understanding the pathogenesis of OSF and interventions to prevent the disease by educating and bringing about a shift in cultural and behavioural attitudes around areca nut consumption is needed. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD007156-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD007156-sec-0008"></div> <div class="table" id="CD007156-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Any intervention versus no active treatment or placebo for managing oral submucous fibrosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Any intervention versus no active treatment or placebo for managing oral submucous fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient:</b> people with oral submucous fibrosis </p> <p><b>Setting:</b> any primary, secondary or tertiary care setting </p> <p><b>Intervention:</b> any medical, surgical or physical therapy </p> <p><b>Comparison:</b> placebo or no active treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Follow‐up</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks</b> </p> <p><b>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Number of participants (number of studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported resumption of normal eating, chewing and speech</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Outcome not reported by included studies</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Antioxidant vs placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo groups was 24.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.11 increase</b> (0.46 increase to 5.77 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>520 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊖⊖<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours antioxidant</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo groups was 25.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 8.83 increase</b> (8.22 increase to 9.45 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>620 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊖<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours antioxidant</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo group was 30.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.41 reduction</b> (5.74 reduction to 2.92 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊖⊖<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Burning sensation</b> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo groups was 71.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 30.92 reduction</b> </p> <p>(31.57 reduction to 30.27 reduction)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊖<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours antioxidant</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo groups was 72.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 70.82 reduction</b> </p> <p>(94.39 reduction to 47.25 reduction)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>500 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊖<br/><b>Moderate</b><sup>b,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours antioxidant</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo group was 42.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 27.60 reduction</b> (36.21 reduction to 18.99 reduction) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊖<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours antioxidant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Any</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (minor) – flatulence and bloating</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Pentoxifylline vs placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo group was 23.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.80 increase</b> (1.02 increase to 2.58 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊖⊖<br/><b>Low</b><sup>b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours pentoxifylline</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo groups was 24.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.15 reduction</b> (5.04 reduction to 4.74 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>a,b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Burning sensation</b> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo group was 33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 7.00 reduction</b> (28.8 reduction to 42.8 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No adverse effects data reported</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Dexamethasone vs placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo group was 28.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.80 reduction</b> (6.30 reduction to 2.70 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo group was 29.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.1 reduction</b> (6.77 reduction to 2.57 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Burning sensation</b> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo group was 52.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 52.00 reduction</b> (62.04 reduction to 41.96 reduction) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo group was 46.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 46.00 reduction</b> (53.44 reduction to 38.56 reduction) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Any</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Vasodilator vs placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo groups was 28.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.51 increase</b> (0.99 reduction to 6.01 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo groups was 29.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 4.04 increase</b> (1.93 reduction to 10.02 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Burning sensation</b> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo groups was 64.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 38.79 reduction</b> (52.06 reduction to 25.53 reduction) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>a,b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo groups was 60.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 51.02 reduction</b> (72.85 reduction to 29.20 reduction) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>a,b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Any</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 (minor) – transient flushing and upper trunk warmness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Hydrocortisone + hyaluronidase vs placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo group was 33.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 4.88 reduction</b> (12.87 reduction to 3.11 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Burning sensation</b><sup>e</sup> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Any</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No adverse effects data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Physiotherapy vs no active treatment</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for control group was 33.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.50 increase</b> (7.72 reduction to 8.72 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Burning sensation</b><sup>e</sup> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No adverse effects data reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>VAS:</b> visual analogue scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level due to inconsistency (substantial heterogeneity).<br/><sup>b</sup> Downgraded one level due to serious concerns regarding risk of bias.<br/><sup>c</sup> Downgraded two levels due to very serious concerns regarding imprecision of effect estimate.<br/><sup>d</sup> Downgraded one level due to serious concerns regarding imprecision of effect estimate.<br/><sup>e</sup> As the heterogeneity between studies seemed to relate to magnitude rather than direction of effect, we did not downgrade for inconsistency. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD007156-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD007156-sec-0009"></div> <p>Oral submucous fibrosis (OSF) is a chronic disease of the oral cavity. It is characterised by the progressive build‐up of constricting bands of collagen in the cheeks and adjacent structures of the mouth, which can cause problems with speech, swallowing, and can severely restrict mouth opening and tongue movement. Systematic reviews estimate a rate of 4.6% to 5.2% of malignant transformation reported in longitudinal studies of OSF, with an annual transformation rate of 0.73% to 0.98% (<a href="./references#CD007156-bbs2-0138" title="IoccaO , SollecitoTP , AlawiF , WeinsteinGS , NewmanJG , De VirgilioA . Potentially malignant disorders of the oral cavity and oral dysplasia: a systematic review and meta-analysis of malignant transformation rate by subtype. Head &amp; Neck2020;4:539-55.">Iocca 2020</a>; <a href="./references#CD007156-bbs2-0142" title="KujanO , MelloFW , WarnakulasuriyaS . Malignant transformation of oral submucous fibrosis: a systematic review and meta-analysis. Oral Diseases2020;27:1936-46.">Kujan 2020</a>). The mechanism by which malignant transformation occurs is not well understood. </p> <p>The prevalence of OSF varies widely between countries, and even between communities and geographical regions within those countries, ranging from 0.1% to 30% (<a href="./references#CD007156-bbs2-0154" title="RaoNR , VillaA , MoreCB , JayasingheRD , KerrAR , JohnsonNW . Oral submucous fibrosis: a contemporary narrative review with a proposed inter-professional approach for an early diagnosis and clinical management. Journal of Otolaryngology-Head &amp; Neck Surgery2020;49(1):3.">Rao 2020</a>). One epidemiological study in central India noted that there was a prevalence of nearly five times as many males with OSF as females, though incidence was higher in females (<a href="./references#CD007156-bbs2-0136" title="HazareyVK , ErlewadDM , MundheKA , UghadeSN . Oral submucous fibrosis: study of 1000 cases from central India. Journal of Oral Pathology &amp; Medicine2007;36(1):12-7.">Hazarey 2007</a>). In Taiwan, one study demonstrated that there had been an increase in prevalence from 8.3 per 100,000 in 1996 to 16.2 per 100,000 in 2013 (<a href="./references#CD007156-bbs2-0159" title="Yang S-F, Wang Y-H, Su N-Y, Yu H-C, Wei C-Y, Yu C-H, et al. Changes in prevalence of precancerous oral submucous fibrosis from 1996 to 2013 in Taiwan: a nationwide population-based retrospective study. Journal of the Formosan Medical Association2018;117(2):147-52.">Yang 2018</a>). Worldwide estimates indicate that at least five million people may be affected (<a href="./references#CD007156-bbs2-0128" title="AzizSR . Oral submucous fibrosis: case report and review of diagnosis and treatment. Journal of Oral and Maxillofacial Surgery2008;66(11):2386-9.">Aziz 2008</a>). The condition is more commonly found in people in the Asian subcontinent and the Far East, but, as a result of transmigration patterns, an increasing number of cases are being seen in other countries (<a href="./references#CD007156-bbs2-0156" title="SukumarS , ColemanHG , CoxSC . Areca nut chewing in an expatriate population in Sydney: report of two cases. Australian Dental Journal2012;57(3):373-8.">Sukumar 2012</a>). </p> <p>The aetiology of OSF is multifactorial: chewing of the areca nut (from the areca catechu plant), excessive use of chillies and spices, poor nutrition and genetic predisposition have all been suggested as causative factors (<a href="./references#CD007156-bbs2-0136" title="HazareyVK , ErlewadDM , MundheKA , UghadeSN . Oral submucous fibrosis: study of 1000 cases from central India. Journal of Oral Pathology &amp; Medicine2007;36(1):12-7.">Hazarey 2007</a>). Chewing of betel quid (areca nut, lime and tobacco) as well as other areca nut‐containing products (e.g. paan masala and gutka) for mouth freshening and a mild euphoric effect is a relatively common practice in India, Pakistan and Sri Lanka. Other combinations, as well as a variety of packaged products, are available in parts of the Far East, particularly China, Taiwan and Malaysia. </p> <p>Epidemiological studies have demonstrated an association between chewing of areca nut products and the incidence of OSF (<a href="./references#CD007156-bbs2-0143" title="Lee C-H, Min-Shan KoA , WarnakulasuriyaS , Yin B-L, Sunarjo, ZainRB , et al. Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia. International Journal of Cancer2011;129(7):1741-51.">Lee 2011</a>), as well as highlighting the significant contribution of smoking and alcohol consumption to the malignant transformation of OSF (<a href="./references#CD007156-bbs2-0145" title="LiuB , ShenM , XiongJ , YuanY , WuX , GaoX , et al. Synergistic effects of betel quid chewing, tobacco use (in the form of cigarette smoking), and alcohol consumption on the risk of malignant transformation of oral submucous fibrosis (OSF): a case-control study in Hunan Province, China. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(3):337-45.">Liu 2015</a>). </p> <p>The precise mode of action of the various chemical constituents of areca nut on the oral tissues is unclear. It has been suggested that these constituents interfere with the deposition or breakdown of collagen, with the cytokine tumour growth factor‐beta (TGF‐β) being key in mediating the OSF pathway (<a href="./references#CD007156-bbs2-0125" title="ArakeriG , RaiKK , HunasgiS , MerkxMA , GaoS , BrennanPA . Oral submucous fibrosis: an update on current theories of pathogenesis. Journal of Oral Pathology &amp; Medicine2017;46(6):406-12.">Arakeri 2017a</a>). Other genetic and autoimmune factors may have a bearing on the pathogenesis of OSF. There are reports that copper from sources such as areca nut and drinking water may contribute to the pathogenesis of OSF (<a href="./references#CD007156-bbs2-0123" title="AngadiPV , RaoSS . Areca nut in pathogenesis of oral submucous fibrosis: revisited. Oral and Maxillofacial Surgery2011;15(1):1-9.">Angadi 2011</a>; <a href="./references#CD007156-bbs2-0124" title="ArakeriG , HunasgiS , ColbertS , MerkxMA , BrennanPA . Role of drinking water copper in pathogenesis of oral submucous fibrosis: a prospective case control study. British Journal of Oral and Maxillofacial Surgery2014;52(6):507-12.">Arakeri 2014</a>). Research indicates that the absence of tobacco in preparations of areca/betel quid, as used in Taiwan, does not reduce the likelihood of developing OSF (<a href="./references#CD007156-bbs2-0158" title="Yang Y-H, Lee H-Y, TungS , Shieh T-Y. Epidemiological survey of oral submucous fibrosis and leukoplakia in Aborigines of Taiwan. Journal of Oral Pathology &amp; Medicine2001;30(4):213-9.">Yang 2001</a>). </p> <section id="CD007156-sec-0010"> <h3 class="title" id="CD007156-sec-0010">Description of the condition</h3> <p>Symptoms of OSF vary and may include progressive restriction of swallowing and mouth opening, pain, burning sensation exacerbated by spicy food and xerostomia. </p> <p>Clinical findings in OSF are largely dependent on the severity of the disease, with early stages typically presenting with stomatitis, mucosal ulcers and fibrosis of ruptured vesicles and ulcers. The later stages involve the presence of fibrous bands in the cheeks and lips; depigmented gums and mucosa; rubbery and deformed soft palate and uvula; and a blanched, leathery floor of the mouth (<a href="./references#CD007156-bbs2-0151" title="PindborgJJ . Oral submucous fibrosis: a review. Annals of the Academy of Medicine, Singapore1989;18(5):603-7.">Pindborg 1989</a>). </p> <p>A number of classification and staging systems for OSF have been used to help determine the type of intervention required (<a href="./references#CD007156-bbs2-0148" title="MoreCB , DasS , PatelH , AdaljaC , KamatchiV , VenkateshR . Proposed clinical classification for oral submucous fibrosis. Oral Oncology2012;48(3):200-2.">More 2012</a>). Diagnosis of OSF should be based on a thorough history and clinical examination, and confirmed by histopathology of the lesion. Several grading systems have been proposed to classify people with OSF according to disease severity. However, there is no consensus between centres about which grading system is most appropriate. </p> </section> <section id="CD007156-sec-0011"> <h3 class="title" id="CD007156-sec-0011">Description of the intervention</h3> <p>Medical treatment options for OSF include inflammatory modulators; vitamin and mineral supplements; antioxidants; and a range of medicines that promote tissue perfusion or encourage fibrolytic activity, such as intralesional steroids, colchicine, immunised milk, hyaluronidase, human placental extracts, chemotrypsin, pentoxifylline and collagenase. In addition, anti‐TGF‐β agents, copper chelators, turmeric, curcumin and aloe vera have been posited as potential treatments for OSF. </p> <p>Where there is restriction of mouth opening, surgical interventions have been employed. Release of fibrotic bands has been used in mild cases, whereas masticatory myotomy or coronoidectomy, followed by resurfacing with flaps such as buccal fat pad, nasolabial or radial forearm free flaps, have been used in more extreme cases. </p> <p>Physical therapy such as mouth opening devices or physiotherapy can also be provided alone or as an adjunct to medical and surgical intervention. </p> <p>All treatment regimens should include patient education and areca nut habit cessation. If used in the early stages of OSF, such management may result in reduction or alleviation of symptoms (<a href="./references#CD007156-bbs2-0126" title="ArakeriG , RaiKK , BoraksG , PatilSG , AljababAS , MerkxMA , et al. Current protocols in the management of oral submucous fibrosis: an update. Journal of Oral Pathology &amp; Medicine2017;46(6):418-23.">Arakeri 2017b</a>). </p> <p>There is no reported minimum clinically important difference (MCID) in mouth opening for people with OSF. An absolute change of 10 mm has been suggested as the MCID in a temporomandibular joint dysfunction population (<a href="./references#CD007156-bbs2-0140" title="KaurA , RustagiN , GanesanA , NihadhaPM , KumarP , ChaudhryK . Minimal clinically important difference of mouth opening in oral submucous fibrosis patients: a retrospective study. Journal of the Korean Association of Oral and Maxillofacial Surgeons2022;48(3):167-73.">Kaur 2022</a>). </p> <p>There is no reported MCID in visual analogue scale (VAS) scores for burning sensation experienced by people with OSF. A systematic review of MCIDs in chronic pain conditions has suggested that a relative reduction in VAS scores of 32% may represent an important improvement in symptoms to people experiencing chronic pain (<a href="./references#CD007156-bbs2-0150" title="OlsenMF , BjerreE , HansenMD , TendalB , HildenJ , HróbjartssonA . Minimum clinically important differences in chronic pain vary considerably by baseline pain and methodological factors: systematic review of empirical studies. Journal of Clinical Epidemiology2018;101:87-106.">Olsen 2018</a>). In lieu of validated MCID values for people with OSF, we have used this as an estimate of clinically important results. </p> </section> <section id="CD007156-sec-0012"> <h3 class="title" id="CD007156-sec-0012">How the intervention might work</h3> <p>Medical management of OSF, both topical and systemic, may improve symptoms by several possible mechanisms. These include correcting nutritional deficiencies, promoting normal tissue regeneration, fibrinolysis, modulating antifibrotic immune pathways, and promoting blood flow through anticoagulant and vasodilatory activity (<a href="./references#CD007156-bbs2-0141" title="KerrAR , WarnakulasuriyaS , MighellAJ , DietrichT , NasserM , RimalJ , et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Diseases2011;17(s1):42-57.">Kerr 2011</a>). </p> <p>Surgical interventions act through mechanical means to improve mouth opening, enabling resumption of speech, normal eating and chewing, as well as facilitating monitoring for early cancerous lesions (<a href="./references#CD007156-bbs2-0126" title="ArakeriG , RaiKK , BoraksG , PatilSG , AljababAS , MerkxMA , et al. Current protocols in the management of oral submucous fibrosis: an update. Journal of Oral Pathology &amp; Medicine2017;46(6):418-23.">Arakeri 2017b</a>). </p> <p>Physical therapy may influence tissue remodelling through physical movements and localised heat application (<a href="./references#CD007156-bbs2-0141" title="KerrAR , WarnakulasuriyaS , MighellAJ , DietrichT , NasserM , RimalJ , et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Diseases2011;17(s1):42-57.">Kerr 2011</a>). </p> </section> <section id="CD007156-sec-0013"> <h3 class="title" id="CD007156-sec-0013">Why it is important to do this review</h3> <p>At the time this review was first published in 2008, there were six studies, of which only two were randomised controlled trials (RCTs) that were acceptable for inclusion (<a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>). It was not possible to combine the results in meta‐analyses and these findings were reported narratively. The authors of the original review were unable to draw firm conclusions due to methodological and reporting issues. Since then, numerous new trials have been published. Furthermore, the prevalence of OSF is increasing and the significant impact on the quality of life of individuals is clearer. There are substantial management challenges in treatment of OSF and uncertainty surrounding the most appropriate treatment modalities. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD007156-sec-0014" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD007156-sec-0014"></div> <p>To evaluate the benefits and harms of interventions for the management of oral submucous fibrosis. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD007156-sec-0015" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD007156-sec-0015"></div> <section id="CD007156-sec-0016"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD007156-sec-0017"> <h4 class="title">Types of studies</h4> <p>We considered only randomised controlled trials (RCTs) for inclusion in this review. We excluded studies that did not include participants with biopsy‐confirmed OSF or studies that used split‐mouth designs. </p> </section> <section id="CD007156-sec-0018"> <h4 class="title">Types of participants</h4> <p>People of any age with a confirmed diagnosis, by clinical examination and biopsy, of OSF. </p> </section> <section id="CD007156-sec-0019"> <h4 class="title">Types of interventions</h4> <p>As there is no established standard of care in OSF, we considered our main findings to be any intervention compared with placebo. The interventions of interest included systemic, intralesional or topical drugs, of any dosage, duration or delivery method; surgical procedures; and others such as physiotherapy, local heat therapy, jaw stretching exercises. We also considered comparisons of these interventions against each other. </p> </section> <section id="CD007156-sec-0020"> <h4 class="title">Types of outcome measures</h4> <section id="CD007156-sec-0021"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD007156-list-0001"> <li> <p>Participant‐reported resumption of normal eating, chewing and speech.</p> </li> <li> <p>Change or improvement in maximal mouth opening, measured as the interincisal distance.</p> </li> <li> <p>Improvement in range of jaw movement using any validated assessment tool.</p> </li> <li> <p>Change in severity of oral/mucosal burning pain/sensation using any recognised validated pain scale. </p> </li> <li> <p>Adverse effects related to any clinically diagnosed reactions to any of the active interventions (as reported in the included studies) </p> </li> </ul> </p> </section> <section id="CD007156-sec-0022"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD007156-list-0002"> <li> <p>Quality of life as assessed by any validated questionnaire, either generic or oral health specific. </p> </li> <li> <p>Postoperative discomfort or pain as a result of the intervention: participant‐assessed using any validated pain scale. </p> </li> <li> <p>Participant satisfaction assessed by a validated questionnaire.</p> </li> <li> <p>Hospital admission: length of stay.</p> </li> <li> <p>Direct costs of medication, hospital bed days and any associated inpatient costs for the surgical interventions. </p> </li> </ul> </p> </section> </section> </section> <section id="CD007156-sec-0023"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD007156-sec-0024"> <h4 class="title">Electronic searches</h4> <p>Cochrane Oral Health's Information Specialist conducted systematic searches in the following databases for RCTs. There were no language, publication year or publication status restrictions. </p> <p> <ul id="CD007156-list-0003"> <li> <p>Cochrane Oral Health's Trials Register (searched 5 September 2022) (<a href="./appendices#CD007156-sec-0144">Appendix 1</a>) </p> </li> <li> <p>Cochrane Central Register of Controlled Trials (CENTRAL; 2022, Issue 8) in the Cochrane Library (<a href="./appendices#CD007156-sec-0145">Appendix 2</a>) </p> </li> <li> <p>MEDLINE Ovid (1946 to 5 September 2022) (<a href="./appendices#CD007156-sec-0146">Appendix 3</a>) </p> </li> <li> <p>Embase Ovid (1980 to 5 September 2022) (<a href="./appendices#CD007156-sec-0147">Appendix 4</a>) </p> </li> </ul> </p> <p>Dr Xinyu Wu and Dr Rui Lu translated non‐English language papers.</p> <p>We modelled subject strategies on the search strategy designed for MEDLINE Ovid. Where appropriate, we combined them with subject strategy adaptations of the highly sensitive search strategies designed by Cochrane for identifying RCTs and controlled clinical trials (as described in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD007156-bbs2-0144" title="LefebvreC , GlanvilleJ , BriscoeS , FeatherstoneR , LittlewoodA , MarshallC , et al. Technical Supplement to Chapter 4: Searching for and selecting studies. In: Higgins JP, Thomas J, Chandler J, Cumpston MS, Li T, Page MJ, Welch VA, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 6.3 (updated February 2022). Cochrane, 2022. Available from training.cochrane.org/handbook/archive/v6.3.">Lefebvre 2022</a>)). </p> </section> <section id="CD007156-sec-0025"> <h4 class="title">Searching other resources</h4> <p>Cochrane Oral Health's Information Specialist searched the following trial registries for ongoing studies. </p> <p> <ul id="CD007156-list-0004"> <li> <p>US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (<a href="https://clinicaltrials.gov" target="_blank">clinicaltrials.gov</a>; searched 5 September 2022) (<a href="./appendices#CD007156-sec-0148">Appendix 5</a>) </p> </li> <li> <p>World Health Organization International Clinical Trials Registry Platform (<a href="https://apps.who.int/trialsearch" target="_blank">apps.who.int/trialsearch</a>; searched 5 September 2022) (<a href="./appendices#CD007156-sec-0149">Appendix 6</a>) </p> </li> </ul> </p> <p>We searched the reference lists of relevant articles, and where possible, we contacted the investigators by email to request further trial details and information about any additional trials. </p> </section> </section> <section id="CD007156-sec-0026"> <h3 class="title" id="CD007156-sec-0026">Data collection and analysis</h3> <section id="CD007156-sec-0027"> <h4 class="title">Selection of studies</h4> <p>Three review authors (AJ, TL and BV) independently undertook screening by title and abstract, and obtained full‐text copies of all potentially relevant articles. Three review authors (AJ, TL and BV) then independently screened the full‐text articles for compliance with the inclusion and exclusion criteria, following initial piloting of these criteria to ensure consistency of application. We resolved any discrepancies through consensus, and then through inclusion of fourth and fifth review authors (JT and VRA) where agreement was not reached. Reasons for exclusion are noted in the <a href="./references#CD007156-sec-0161" title="">Characteristics of excluded studies</a> table. </p> </section> <section id="CD007156-sec-0028"> <h4 class="title">Data extraction and management</h4> <p>At least two review authors (AJ, TL and BV) independently collected study details and outcome data using a predetermined form designed for this purpose. Study details can be found in the <a href="#CD007156-sec-0042">Included studies</a> section and <a href="./references#CD007156-sec-0160" title="">Characteristics of included studies</a> table. We included data only if consensus was reached. We discussed any disagreements and, if required, consulted a third or fourth review author. We extracted the following details. </p> <p> <ul id="CD007156-list-0005"> <li> <p>Study methods: country of conduct, method of allocation, blinding of participants and investigators (if feasible), exclusion of participants after randomisation, numbers lost to follow‐up. </p> </li> <li> <p>Participants: sample size, age, sex, inclusion and exclusion criteria.</p> </li> <li> <p>Intervention: type of procedure, mode of administration, dose, frequency and duration of usage (for medicinal interventions). </p> </li> <li> <p>Control: type, dose and frequency of any comparison or placebo.</p> </li> <li> <p>Outcomes: primary and secondary outcomes.</p> </li> <li> <p>Adverse effects/events.</p> </li> </ul> </p> <p>If stated, we recorded the sources of funding for any of the included studies.</p> </section> <section id="CD007156-sec-0029"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>At least two review authors (AJ, BV and TL) independently assessed the risk of bias of included trials using the Cochrane RoB 1 tool (<a href="./references#CD007156-bbs2-0137" title="HigginsJP , Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). We considered the following factors: random sequence generation, allocation concealment, blinding of participants and investigators, blinding of outcome assessment, incomplete outcome data, selective reporting and other bias. We categorised each domain as low, high or unclear risk of bias. We compared the judgements of different review authors and resolved any inconsistencies through discussion. Where we judged the risk of bias to be unclear, we contacted trial authors for clarification. </p> <p>We made an overall judgement of risk of bias for each study. We assessed studies to have an overall low risk of bias when any plausible bias across all seven domains was unlikely to have altered the results. We assessed studies to have an overall unclear risk of bias when any plausible bias across one or more of the key domains raised some doubt that it may have altered the results. We assessed studies to have an overall high risk of bias when we believed any plausible bias across one or more of the key domains may seriously have altered the results reported in that study. </p> </section> <section id="CD007156-sec-0030"> <h4 class="title">Measures of treatment effect</h4> <p>We used Review Manager 5 to perform the analyses (<a href="./references#CD007156-bbs2-0155" title="Review Manager (RevMan). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>). </p> <p>For continuous data, we calculated mean differences (MD) and standard deviations for each group to express the estimate of effect as MD with 95% confidence interval (CI). When studies reported continuous outcomes on different scales, we used standardised mean difference (SMD) to pool these data in meta‐analysis. We calculated odds ratios and their 95% CIs for dichotomous data where possible. </p> <p>Where there was insufficient information to enable effect measures to be calculated, we provided a narrative report of the summary measures. </p> </section> <section id="CD007156-sec-0031"> <h4 class="title">Unit of analysis issues</h4> <p>The unit of analysis was the individual participant.</p> <p>We grouped time points for outcomes into less than three months, three to six months, and greater than six months, based on the most frequently reported follow‐up intervals used in the studies evaluated. Where there was a choice of time point within these groupings for a primary outcome, we selected the longest follow‐up period available. Where there were multiple‐arm studies, we ensured participants were not double counted in meta‐analyses. </p> </section> <section id="CD007156-sec-0032"> <h4 class="title">Dealing with missing data</h4> <p>We attempted to contact study authors to retrieve any partial or missing data. Where complete data were not available, we planned to impute data when it was deemed sufficiently low risk to do so. No imputation of data was carried out. </p> </section> <section id="CD007156-sec-0033"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed clinical heterogeneity by examining the characteristics of the studies: the similarity between the types of participants, the interventions and the outcomes as specified in the <a href="#CD007156-sec-0016">Criteria for considering studies for this review</a>. </p> <p>We assessed statistical heterogeneity by calculation of the Q statistic with P value set at less than 0.10. This was quantified by the calculation of the I<sup>2</sup> statistic for heterogeneity. We judged values above 75% to represent considerable heterogeneity and values from 50% to 74% as substantial, based on guidance in the <i>Cochrane Handbook for Systematic Reviews of Interventions (</i><a href="./references#CD007156-bbs2-0137" title="HigginsJP , Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>). </p> <p>We pooled results of trials to provide estimates of the effectiveness of the interventions only if we judged that the included studies were sufficiently homogeneous with respect to intervention received and study participant characteristics, using the random‐effects model of meta‐analysis. </p> </section> <section id="CD007156-sec-0034"> <h4 class="title">Assessment of reporting biases</h4> <p>Had we found a sufficient number of studies within each intervention group to enable reliable assessment by funnel plots or Egger's test, we would have used these to consider any possible reporting bias. </p> </section> <section id="CD007156-sec-0035"> <h4 class="title">Data synthesis</h4> <p>We followed Cochrane statistical guidelines for data synthesis. Review authors (AJ, JT and VRA) analysed the data using Review Manager 5 and reported them according to Cochrane criteria (<a href="./references#CD007156-bbs2-0137" title="HigginsJP , Green S editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from training.cochrane.org/handbook/archive/v5.1/.">Higgins 2011</a>; <a href="./references#CD007156-bbs2-0155" title="Review Manager (RevMan). Version 5.4. Copenhagen: The Cochrane Collaboration, 2020.">Review Manager 2020</a>). </p> <p>We performed meta‐analysis using the random‐effects model. Forest plots displayed means and 95% CIs. Where it was not possible to pool data or where data reporting did not allow for quantitative analysis, we provided a narrative description of the findings. </p> </section> <section id="CD007156-sec-0036"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>We subgrouped studies according to the putative primary mechanism of action of the intervention. Because interventions between subgroups differed substantially in mode of delivery and mechanism of action, we considered it inappropriate to undertake comparisons between subgroups. </p> <p>We had planned to undertake a subgroup analysis based on staging of OSF. We did not find sufficient data to undertake this. </p> </section> <section id="CD007156-sec-0037"> <h4 class="title">Sensitivity analysis</h4> <p>As all but one study was at high or unclear risk of bias, we did not undertake a sensitivity analysis. </p> </section> <section id="CD007156-sec-0038"> <h4 class="title">Summary of findings and assessment of the certainty of the evidence</h4> <p>We prepared a summary of review table, which presented each comparison and the primary outcomes. As there is no established standard of care in OSF, we considered 'any intervention versus placebo' to be our main comparison of interest (<a href="./full#CD007156-tbl-0001">summary of findings Table 1</a>). </p> <p>Two review authors (AJ and JT) assessed the certainty of evidence using GRADEpro GDT software as high, moderate, low or very low (<a href="./references#CD007156-bbs2-0131" title="GRADEpro GDT. Version accessed 15 August 2023. Hamilton (ON): McMaster University (developed by Evidence Prime). Available at gradepro.org.">GRADEpro GDT</a>). Factors that were assessed and contributed to this evaluation using the GRADE methodology were: risk of bias, inconsistency between studies, indirectness, imprecision and likely publication bias. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD007156-sec-0039" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD007156-sec-0039"></div> <section id="CD007156-sec-0040"> <h3 class="title">Description of studies</h3> <p>See <a href="./references#CD007156-sec-0160" title="">Characteristics of included studies</a>; <a href="./references#CD007156-sec-0161" title="">Characteristics of excluded studies</a>; <a href="./references#CD007156-sec-0162" title="">Characteristics of studies awaiting classification</a>; and <a href="./references#CD007156-sec-0163" title="">Characteristics of ongoing studies</a> tables. </p> <section id="CD007156-sec-0041"> <h4 class="title">Results of the search</h4> <p>Up to September 2022, the search identified 1108 references for this version of the review from the electronic searches. After removing duplicates, 605 references remained. We considered 121 articles in full text and excluded 79 of these, with reasons. We included 28 new studies (29 references). We included two studies from a previous version of this review. Therefore, we included 30 RCTs (31 records) in this review (<a href="#CD007156-fig-0001">Figure 1</a>). Three studies are awaiting classification, and there are eight ongoing studies. </p> <div class="figure" id="CD007156-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="original image" data-id="CD007156-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-FIG-01.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"></div> </div> </section> <section id="CD007156-sec-0042"> <h4 class="title">Included studies</h4> <p>For a summary of each included study, see the <a href="./references#CD007156-sec-0160" title="">Characteristics of included studies</a> table. </p> <section id="CD007156-sec-0043"> <h5 class="title">Characteristics of the trials</h5> <section id="CD007156-sec-0044"> <h6 class="title">Design</h6> <p>Twenty‐two RCTs used a two‐arm parallel‐group design (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>), seven used a three‐arm parallel‐group design (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>), and one used a four‐arm parallel‐group design (<a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>). </p> </section> <section id="CD007156-sec-0045"> <h6 class="title">Setting</h6> <p>Twenty‐seven studies were conducted in India (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>), two in China (<a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>), and one in Nepal (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>). All studies were single centre and conducted in university clinics or hospitals. </p> </section> <section id="CD007156-sec-0046"> <h6 class="title">Funding</h6> <p>Seven studies reported that they received no funding (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>), one study received institutional funding (<a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>), and two studies received funding from state medical boards (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>). Twenty studies did not make funding declarations (<a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). </p> </section> </section> <section id="CD007156-sec-0047"> <h5 class="title">Participants</h5> <p>The total number of participants included in the trials was 2176, with the number per study ranging from eight to 400. Studies did not consistently report baseline characteristics of participants such as age, sex or disease stage. </p> </section> <section id="CD007156-sec-0048"> <h5 class="title">Interventions</h5> <p><a href="#CD007156-tbl-0002">Table 1</a> shows a summary of the interventions used in the studies. </p> <div class="table" id="CD007156-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of the interventions</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Delivery method</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Details of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Steroids (alone or in combination)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Betamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of betamethasone 4 mg/mL diluted in 1 mL of 2% xylocaine bilaterally biweekly for 6 months + habit cessation advice and oral prophylaxis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Submucosal injections of dexamethasone 2 mL (4 mg/mL) with 1 mL of 2% lignocaine with adrenaline (1:80,000), bilateral buccal mucosa, biweekly for 5 weeks with cheek massage and mouth opening physiotherapy 5 times daily and passive tongue spatula placement between teeth </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combination hyaluronidase + dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Submucosal injections of a combination of dexamethasone 1 mL (4 mg/mL) and hyaluronidase (750 IU) diluted with 1 mL of 2% lignocaine with adrenaline (1:80,000) and 1 mL of water for injection. Bilateral buccal mucosa, biweekly for 5 weeks with cheek massage and mouth opening physiotherapy 5 times daily and passive tongue spatula placement between teeth </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hydrocortisone and hyaluronidase</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Injection of a combination of hydrocortisone acetate (1.5 mL of 25 mg/mL) and hyaluronidase (1500 IU) submucosally in retromolar trigone, soft palate and cheek bilaterally (half dose on each side). Performed every 15 days for 22 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Triamcinolone and hyaluronidase</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Injection of a combination of triamcinolone acetonide (10 mg/mL) and hyaluronidase (1500 IU) submucosally in retromolar trigone, soft palate and cheek bilaterally (half dose on each side). Performed every 15 days for 22 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dexamethasone + hyaluronidase + 2% lidocaine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection 2 mL of dexamethasone with 1500 IU hyaluronidase mixed with 1 mL of 2% lidocaine with 1:80,000 adrenaline twice‐weekly for 6 weeks with mouth opening physiotherapy, cheek blowing exercises and habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hydrocortisone + hyaluronidase</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of hyaluronidase 1500 U and hydrocortisone 100 mg in sterile water, biweekly for 4 weeks with habit cessation advice and correction of any underlying anaemia with mebendazole 100 mg twice daily for 3 days and ferrous sulphate 200 mg and folic acid 5 mg for 4 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral lycopene + betamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local + Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene 16 mg orally daily + 2 × 4 mg intralesional injection of betamethasone for 2 months with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Triamcinolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of triamcinolone 2 mg after 5 minutes of local anaesthetic cream, once per week for 20 weeks with habit cessation advice, and mouth stretching exercises 3 times per day for 15 minutes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Salvianolic acid + triamcinolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of both triamcinolone 2 mg and salvianolic acid B 4 mg after 5 minutes of local anaesthetic cream application, at weekly intervals for 20 weeks with habit cessation advice, and mouth stretching exercises 3 times per day for 15 minutes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dexamethasone + hyaluronidase</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of dexamethasone 4 mg/mL, hyaluronidase 1500 IU and 0.5 mL of 2% lidocaine with adrenaline administered weekly at multiple sites for 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prednisolone + salvia miltorrhiza</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly intralesional injections of 2 mL prednisolone acetate (25 g/L) and 1 mL lidocaine (20 g/L) and 2 mL of compound salvia miltorrhiza (1.5 g/mL) and 1 mL lidocaine (20 g/L) for 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prednisolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly intralesional injection of prednisolone acetate (25 g/L) and 1 mL lidocaine (20 g/L) for 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hyaluronidase + hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Injection of hyaluronidase 1500 U and hydrocortisone 100 mg in sterile water biweekly for 4 weeks with habit cessation advice, diet advice and correction of underlying anaemia with mebendazole 100 mg twice daily for 3 days and ferrous sulphate 200 mg and folic acid 5 mg for 4 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Surgery (alone or in combination)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery – extended nasolabial flaps</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral incision and release of buccal fibrous bands, coronoidectomy, reconstruction with extended nasolabial flaps, mouth opening physiotherapy for 6 months postoperatively </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery – nasolabial flap</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excision of fibrous bands, mouth opening using Heister's mouth gag (35–40 mm), coronoidectomy and reconstruction with nasolabial flap. Extraction of third molars, intensive physiotherapy using Heister's mouth gag 5–6 times daily for 20–30 minutes from day 3 postoperatively onwards </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery – abdominal dermal fat graft</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excision of fibrous bands, mouth opening using Heister's mouth gag (35–40 mm), coronoidectomy, and reconstruction with abdominal dermal fat graft. Extraction of third molars, intensive physiotherapy using Heister's mouth gag 5–6 times daily for 20–30 minutes from day 3 postoperatively onwards </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery – buccal fat pad graft</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral incision and release of buccal fibrous bands, coronoidectomy, reconstruction with buccal fat pad graft, mouth opening physiotherapy for 6 months postoperatively </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery + placental extract</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral buccal mucosal fibrotomy and coronoidectomy repaired with buccal fat pad. Placental extract applied topically 4 hourly for 4 weeks with physiotherapy and oral hygiene instruction </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral buccal mucosal fibrotomy and coronoidectomy repaired with buccal fat pad with physiotherapy and oral hygiene instruction </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery + Heister jaw opener</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mouth opening physiotherapy using Heister jaw opener instrument between teeth 5–6 times daily for 6 months followed by another 12 months at reduced frequency alongside fibrous band incision with buccal fat pad repair, bilateral coronoidectomy, extraction of third molars, oral supplements of vitamin A 50,000 IU, vitamin B complex 200 mg, vitamin C 500 mg and beta‐carotene, along with topical application of triamcinolone acetonide 0.1% applied over the surgical area for ≥ 6 months postoperatively </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery + wooden tongue depressors</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mouth opening physiotherapy using placement of wooden tongue depressors between teeth 5–6 times daily for 6 months, followed by another 12 months at reduced frequency. Fibrous band incision with buccal fat pad flap repair, bilateral coronoidectomy, and extraction of third molars. Oral supplements of vitamin A 50,000 IU, vitamin B complex 200 mg, vitamin C 500 mg and beta‐carotene, along with topical application of triamcinolone acetonide 0.1% applied over the surgical area for ≥ 6 months postoperatively </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Physiotherapy (alone or in combination)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tongue spatulas placed passively between anterior teeth holding jaws open for 1 minute 5 times per session 5 times per day for 4 months with the addition of an additional spatula every 5th day with habit cessation advice, diet advice and correction of any underlying anaemia with mebendazole 100 mg twice daily for 3 days and ferrous sulphate 200 mg and folic acid 5 mg for 4 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physiotherapy + ultrasound therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ultrasound therapy for 7 minutes over 1 week (intervals unknown) + jaw opening exercises – maximal opening for 5 seconds, lateral deviations and protrusion of mandible repeated 10 times </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Jaw opening exercises – maintain maximal mouth opening for 5 seconds, lateral deviations and protrusion of mandible, repeated 10 times for 1 week </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Pentoxifylline</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral pentoxifylline 400 mg twice daily for 30 days then 3 times daily for 6 months + habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral pentoxifylline 2 × 400 mg tablets daily for 30 days then 3 × 400 mg tablets daily for 6 months with 1 multivitamin tablet at night, local heat therapy and mouth opening exercises </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × pentoxifylline 400 mg tablets twice daily for 3 months with habit cessation advice</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × pentoxifylline tablets daily for 15 days, followed by 3 tablets daily for 3.5 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline 400 mg orally twice daily for 3 months with daily mouth opening exercises</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Aloe vera</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera 5 mg gel applied topically to buccal mucosa bilaterally 3 times per day for 3 months with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera 5 mg gel topically 3 times daily for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera gel applied topically to lesions 3 times daily for 3 months with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Lycopene</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene 2 mg capsules twice daily for 6 months with habit cessation advice and oral prophylaxis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene 16 mg orally daily for 2 months with habit cessation advice</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 × lycopene 8 mg capsule twice daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Mixed antioxidants</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mixed antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antioxidant capsules (beta‐carotene 5 mg; mixed carotenoids 5 mg; vitamin E 25 mg; chromium 200 μg; zinc 7.5 mg; manganese 1.5 mg; copper 1 mg; selenium 150 μg; vitamin C 100 mg) orally twice daily for 3 months with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mixed antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 tablet of Turmix (combination curcumin and piperine 300 mg) twice daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mixed antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 tablets of Turmix (Curcumin longa 300 mg, piperine 5 mg) orally for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Oxitard</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oxitard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 Oxitard capsules twice daily for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oxitard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 Oxitard capsules twice daily for 3 months with habit cessation advice</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Spirulina</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina 250 mg orally twice daily for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina 500 mg orally twice daily for 3 months with daily mouth opening exercises</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina 500 mg twice daily for 3 months with habit cessation advice</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Other</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Curcumin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 curcumin 500 mg capsules daily + habit cessation for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Isoxsuprine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Isoxsuprine 10 mg orally 4 times per day for 6 weeks, mouth opening physiotherapy and cheek blowing exercises, habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Xantitol nicotinate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of xantitol nicotinate biweekly for 4 months with mouth opening physiotherapy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Salvianolic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of salvianolic acid B 4 mg after 5 minutes of local anaesthetic cream application at weekly intervals for 20 weeks with habit cessation advice, and mouth stretching exercises 3 times per day for 15 minutes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Salvianolic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 capsule salvianolic acid antioxidant twice daily for 6 weeks with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Levisamole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Levisamole 50 mg tablet orally 3 times daily for 3 consecutive days per week for 3 alternate weeks with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Levisamole + salvianolic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Levisamole 50 mg tablet orally 3 times daily for 3 consecutive days per week for 3 alternate weeks with 1 capsule salvianolic acid twice daily for 6 weeks + habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a> </p> </td> </tr> </tbody> </table> </div> <p>Fourteen trials tested preparations with proposed antioxidant properties administered orally. These were: Oxitard (<a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>), lycopene (<a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>), spirulina (<a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>), 'Turmix' capsules (<a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>), salvianolic acid (<a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>), curcumin (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>), and 'antioxidant capsules' (Lekar Pharma Ltd) (<a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>). </p> <p>Four trials used a single corticosteroid injected locally (betamethasone, dexamethasone, triamcinolone, prednisolone and hydrocortisone) (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>). Five trials used a steroid in combination with hyaluronidase injected locally (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). One trial used a steroid injection combined with salvianolic acid (<a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>). One trial compared a corticosteroid injected locally with oral lycopene (<a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>). </p> <p>Five trials employed systemic pentoxifylline (an anti‐inflammatory and innate immunomodulatory drug) (<a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>). </p> <p>Two trials employed vasodilators injected locally; these were isoxsuprine (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>) and xanthinol nicotinate (<a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). </p> <p>One trial compared levamisole (a drug with proposed immunomodulatory properties) with levamisole combined with an antioxidant (<a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>). </p> <p>Two trials compared two forms of surgery: one trial compared buccal fat pad graft versus extended nasolabial flaps (<a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>), and one trial compared abdominal dermal fat graft versus nasolabial flap (<a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>). One trial compared surgery versus surgery plus a topical application of placental extract (<a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>). One trial compared two forms of physiotherapy after surgery (Heister jaw opener versus wooden tongue depressors) (<a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>). </p> <p>Two trials compared different forms of physiotherapy (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>). </p> <p>Three trials included topical applications of aloe vera gel as a comparator (<a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>). </p> <p>Thirteen trials compared interventions with a placebo or non‐active control: seven antioxidant studies (<a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a> (lycopene); <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a> (curcumin); <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a> (lycopene); <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a> (spirulina); <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a> (Oxitard); <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a> (Turmix – curcumin and piperine 300 mg); <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a> (Turmix – Curcumin longa 300 mg, piperine 5 mg)); two pentoxifylline studies (<a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>); two vasodilator studies (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>); one physiotherapy study (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>); and one aloe vera study (<a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>). </p> <p>Treatment courses varied from one week to 18 months.</p> <p>We evaluated the following comparisons by meta‐analysis.</p> <p> <ul id="CD007156-list-0006"> <li> <p>Any intervention versus placebo</p> </li> <li> <p>Different types of medications versus one another</p> </li> <li> <p>Different surgical techniques versus one another</p> </li> <li> <p>Surgery alone versus surgery plus adjunctive treatments</p> </li> <li> <p>Physiotherapy alone versus physiotherapy plus adjunctive treatments</p> </li> <li> <p>Physiotherapy versus medications</p> </li> <li> <p>Surgery combined with different physiotherapy techniques</p> </li> </ul> </p> </section> <section id="CD007156-sec-0049"> <h5 class="title">Outcomes</h5> <p>No studies reported our primary outcome of interest of participant‐reported resumption of normal eating, chewing and speech. Four trials reported change in 'difficulty in speech', 'difficulty in swallowing', 'difficulty in mouth opening' and 'intolerance to spicy food' (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>). These were presented as frequencies of participants reporting these symptoms before and after interventions. As these are important participant‐reported outcomes, <a href="#CD007156-tbl-0003">Table 2</a> provides a summary. However, interpretation of these findings was difficult. Interincisal distance (change scores, measured in millimetres) and severity of burning sensation (measured using a VAS from 0 mm to 100 mm) were the outcome measures most frequently reported by trials included in this review. Several studies reported pain as distinct from burning sensation, although it was not clear how these were differentiated. The outcomes were measured between one week and 18 months. No trials reported our secondary outcomes. </p> <div class="table" id="CD007156-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Participant‐reported outcome measures</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Follow‐up</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome (s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention – outcome frequency (%) (baseline – endpoint)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control – outcome frequency (%) (baseline – endpoint)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comment</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>100 (50 per group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Curcumin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in mouth opening</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intolerance to spicy food</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Oxitard capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Topical aloe vera gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pentoxifylline 400 mg twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Multivitamin (placebo)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intergroup differences not assessed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intergroup differences not assessed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2 Oxitard capsules twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> </tbody> </table> </div> <section id="CD007156-sec-0050"> <h6 class="title">Maximal mouth opening (interincisal distance (mm))</h6> <p>Twenty‐nine studies used interincisal distance to measure a change or improvement in maximal mouth opening. The units of measurement were either millimetres or centimetres. We converted results to millimetres for quantitative analysis. </p> </section> <section id="CD007156-sec-0051"> <h6 class="title">Burning sensation</h6> <p>Fourteen studies used an assessment of burning sensation measured using a validated scale (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). All studies used a VAS, from either 0 cm to 10 cm or 0 mm to 100 mm. We converted results to millimetres for quantitative analysis. </p> <p>Eight studies reported burning sensation using only non‐validated scales, subjective scores, as a binary measure of presence/absence or were unclear about how this outcome was measured (<a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>). </p> <p>Eight studies did not measure burning sensation (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>). </p> </section> <section id="CD007156-sec-0052"> <h6 class="title">Pain</h6> <p>Six studies reported presence of pain as a binary outcome (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>). <a href="#CD007156-tbl-0004">Table 3</a> shows a summary of these findings. </p> <div class="table" id="CD007156-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pain</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparator(s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Follow‐up</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcomes (s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention A – outcome</b> </p> <p><b>mean difference (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention B – outcome</b> </p> <p><b>mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison</b> </p> <p><b>– outcome mean difference (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comment</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hyaluronidase submucosal injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dexamethasone submucosal injection</p> <p>Hyaluronidase + dexamethasone submucosal injections</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain while opening mouth (VAS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (1.69)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33 (0.72)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.93 (2.15)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P = 0.035)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × 500 mg curcumin capsules once daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain (VAS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.16 (4.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear how pain was differentiated from burning sensation in this study</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparator(s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Follow‐up</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcomes (s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention A – outcome</b> </p> <p><b>frequency (%) (baseline – endpoint)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>—</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison – outcome</b> </p> <p><b>frequency (%) (baseline –endpoint)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comment</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline 400 mg twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multivitamin (placebo)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain associated with lesion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 Oxitard capsules twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical aloe vera gel 5 mg 3 times daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain associated with lesion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 Oxitard capsules twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain associated with lesion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina 250 mg oral twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical aloe vera gel 5 mg 3 times daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain associated with lesion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intergroup differences not measured</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>a</sup> change from baseline reported<br/>SD: standard deviation; VAS: visual analogue scale. </p> </div> </div> </section> <section id="CD007156-sec-0053"> <h6 class="title">Adverse effects</h6> <p>Fifteen studies made statements regarding adverse effects. Of these, six did not encounter adverse effects of treatment (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>), while nine reported adverse effects in treatment groups (<a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>). The 15 remaining studies either did not consider adverse effects at all or did not report data in a usable form (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>). </p> </section> <section id="CD007156-sec-0054"> <h6 class="title">Other outcomes</h6> <p>The studies did not measure our other outcomes: range of jaw movement, quality of life, patient satisfaction, hospital admission or costs. </p> </section> <section id="CD007156-sec-0055"> <h6 class="title">Outcomes not relevant for this review</h6> <p>Trials reported several other outcomes that we did not deem reliable or relevant to this review. See <a href="./appendices#CD007156-sec-0150">Appendix 7</a>. </p> </section> <section id="CD007156-sec-0056"> <h6 class="title">Studies without usable data</h6> <p>We excluded seven studies from meta‐analysis as data were mis‐reported (<a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>) or not reported in a usable format (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>). </p> </section> </section> </section> <section id="CD007156-sec-0057"> <h4 class="title">Excluded studies</h4> <p>Although many of the excluded studies could have been excluded for more than one reason, we recorded only the main reason for exclusion in the <a href="./references#CD007156-sec-0161" title="">Characteristics of excluded studies</a> table. </p> <p>We excluded 39 studies that did not use a histological diagnosis for OSF (<a href="./references#CD007156-bbs2-0033" title="AmbereenA , BhutiaO , RoychoudhuryA , YadavR , KhakhlaDH , VishwakarmaK . Is coronoidectomy superior to coronoidotomy for improving maximum incisal opening in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2021;79(4):863.e1-e7. ">Ambereen 2021</a>; <a href="./references#CD007156-bbs2-0035" title="AnuradhaA , PatilB , AshaVR . Evaluation of efficacy of aloe vera in the treatment of oral submucous fibrosis – a clinical study. Journal of Oral Pathology &amp; Medicine2017;46(1):50-5. [DOI: 10.1111/jop.12463]">Anuradha 2017</a>; <a href="./references#CD007156-bbs2-0041" title="BaptistJ , ShakyaS , OngoleR . Rebamipide to manage stomatopyrosis in oral submucous fibrosis. Journal of Contemporary Dental Practice2016;17(12):1009-12. ">Baptist 2016</a>; <a href="./references#CD007156-bbs2-0042" title="BiswasG , AnupN , KumawatH . Efficacy of lycopene in the management of oral submucous fibrosis – a randomized clinical trial. Indian Journal of Public Health Research and Development2015;6(3):33-7. ">Biswas 2015</a>; <a href="./references#CD007156-bbs2-0045" title="ChandrashekarA , AnnigeriRG , VaU , ThimmasettyJ . A clinicobiochemical evaluation of curcumin as gel and as buccal mucoadhesive patches in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2021;131(4):428-34. ">Chandrashekar 2021</a>; <a href="./references#CD007156-bbs2-0046" title="ChenJ , WuY , PengJ , MaL . Oral opening training increases oral opening in patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University. Medical Sciences]2021;46(7):731-5. ">Chen 2021</a>; <a href="./references#CD007156-bbs2-0048" title="CTRI/2021/09/036499. Effectiveness of Oxitard capsule and immusante tablet towards early stages of oral submucous fibrosis. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2021/09/036499 (first received 14 September 2021). ">CTRI/2021/09/036499</a>; <a href="./references#CD007156-bbs2-0049" title="DagaD , SinghRK , PalUS , GurungT , GangwarS . Efficacy of oral colchicine with intralesional hyaluronidase or triamcinolone acetonide in the Grade II oral submucous fibrosis. National Journal of Maxillofacial Surgery2017;8(1):50-4. [DOI: 10.4103/njms.NJMS_5_17]">Daga 2017</a>; <a href="./references#CD007156-bbs2-0050" title="DasukilS , JenaAK , BoyinaKK , GroverS , AroraG , AhmedZU . Functional outcome of two different grafting techniques in the surgical management of oral submucous fibrosis: a comparative evaluation. Oral and Maxillofacial Surgery2022;26(3):477-83. ">Dasukil 2022</a>; <a href="./references#CD007156-bbs2-0051" title="DatarkarA , AkareA , TayalS . Efficacy of prednisolone mouthwash in management of grade III oral submucous fibrosis: a newer drug regimen. Journal of Maxillofacial and Oral Surgery2020;19(4):532-8. ">Datarkar 2020</a>; <a href="./references#CD007156-bbs2-0052" title="DeepakTA , ManjunathM , ThakurH . Efficacy of curcumin and topical steroids in the treatment for oral submucous fibrosis: a comparative study. Journal of Pharmacy &amp; Bioallied Sciences2021;13(Suppl 1):S542-8. ">Deepak 2021</a>; <a href="./references#CD007156-bbs2-0053" title="GangulyR , SinghV , TiwariAN , MohammadS , PalUS , SinghR , et al. Evaluation of efficacy of herbal preparation in the management of oral submucous fibrosis: a study. International Journal of Research in Ayurveda and Pharmacy2020;11(4):152-60. ">Ganguly 2020</a>; <a href="./references#CD007156-bbs2-0055" title="GuptaA , KumarS , SrivastavaP , RathiVC , SaxenaS , AggarwalA . Effect of trans retinoic acid on patients with oral submucous fibrosis-randomized single-blind monocentric study. Journal of Oral and Maxillofacial Pathology2022;25(3):411. ">Gupta 2022</a>; <a href="./references#CD007156-bbs2-0056" title="HazareyVK , SakrikarAR , GanvirSM . Efficacy of curcumin in the treatment for oral submucous fibrosis – a randomized clinical trial. Journal of Oral and Maxillofacial Pathology2015;19(2):145-52. ">Hazarey 2015</a>; <a href="./references#CD007156-bbs2-0060" title="JiangX , ZhangY , LiF , ZhuY , ChenY , YangS , et al. Allicin as a possible adjunctive therapeutic drug for stage II oral submucous fibrosis: a preliminary clinical trial in a Chinese cohort. International Journal of Oral and Maxillofacial Surgery2015;44(12):1540-6. [DOI: 10.1016/j.ijom.2015.06.015]">Jiang 2015</a>; <a href="./references#CD007156-bbs2-0064" title="KanjaniV , AnnigeriRG , RevanappaMM , RaniA . Efficacy of spirulina along with different physiotherapeutic modalities in the management of oral submucous fibrosis. Annals of Maxillofacial Surgery2019;9(1):23-7. ">Kanjani 2019</a>; <a href="./references#CD007156-bbs2-0067" title="KisaveP , ShekharV , BabuPS , HussainiSW , BhanotR , KumarA , et al. The study of placentrex and hydrocortisone as an adjunct treatment in oral submucous fibrosis. Journal of Family Medicine and Primary Care2020;9(5):2469-74. ">Kisave 2020</a>; <a href="./references#CD007156-bbs2-0070" title="LanjekarAB , BhowateRR , BakhleS , NarayaneA , PawarV , GandaguleR . Comparison of efficacy of topical curcumin gel with triamcinolone-hyaluronidase gel individually and in combination in the treatment of oral submucous fibrosis. Journal of Contemporary Dental Practice2020;21(1):83-90. ">Lanjekar 2020</a>; <a href="./references#CD007156-bbs2-0076" title="MemonAB , RahmanAA , ChannarKA , ZafarMS , KumarN . Evaluating the oral-health-related quality of life of oral submucous fibrosis patients before and after treatment using the OHIP-14 tool. International Journal of Environmental Research and Public Health2022;19(3):1821. ">Memon 2022</a>; <a href="./references#CD007156-bbs2-0077" title="MostafaMG , KhanJA , AhmedS , KamruzzamanM , IslamMR , RahmanMA , et al. Comparison between efficacy of combined use of hyaluronidise and triamcinolone versus hyaluronidise, triamcinolone acetonide and oral colchicine in the treatment of oral submucous fibrosis. Mymensingh Medical Journal2021;30(1):79-84. ">Mostafa 2021</a>; <a href="./references#CD007156-bbs2-0078" title="NihadhaPM , ChughA , KaurA , KumarS , NaveenKH , BhatiaPK , et al. Transdermal fentanyl patch versus standard analgesia in postoperative oral submucous fibrosis patients: a triple blinded, randomised control trial. British Journal of Oral and Maxillofacial Surgery2022;60(9):1246-53. ">Nihadha 2022</a>; <a href="./references#CD007156-bbs2-0079" title="PandeyA , SharmaNK , DhimanNK , JaiswaraC , TiwariP , SinghAK , et al. Comparative evaluation of buccal pad of fat with and without bovine collagen membrane in the management of oral submucous fibrosis: a prospective clinical study. National Journal of Maxillofacial Surgery 2020;11(1):57-63. ">Pandey 2020</a>; <a href="./references#CD007156-bbs2-0081" title="PatilP , HazareyV , ChaudhariR , Nimbalkar-PatilS . Clinical efficacy of a mouth-exercising device adjunct to local ointment intra-lesional injections and surgical treatment for oral submucous fibrosis: a randomized controlled trial. Asian Pacific Journal of Cancer Prevention: APJCP2016;17(3):1255-9. ">Patil 2016a</a>; <a href="./references#CD007156-bbs2-0082" title="PatilPG , HazareyV , ChaudhariR , Nimbalkar-PatilS . A randomized control trial measuring the effectiveness of a mouth-exercising device for mucosal burning in oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2016;122(6):713-8. [DOI: 10.1016/j.oooo.2016.07.026]">Patil 2016b</a>; <a href="./references#CD007156-bbs2-0085" title="PipaliaPR , AnnigeriRG , MehtaR . Clinicobiochemical evaluation of turmeric with black pepper and nigella sativa in management of oral submucous fibrosis – a double-blind, randomized preliminary study. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2016;122(6):705-12. [DOI: 10.1016/j.oooo.2016.07.023]">Pipalia 2016</a>; <a href="./references#CD007156-bbs2-0088" title="RaiA , KaurM , GombraV , HasanS , KumarN . Comparative evaluation of curcumin and antioxidants in the management of oral submucous fibrosis. Journal of Investigative and Clinical Dentistry2019;10(4):e12464. [DOI: 10.1111/jicd.12464]">Rai 2019</a>; <a href="./references#CD007156-bbs2-0089" title="RaizadaMK , SableDM , ChowdheryA , ChavanMS , RajpurohitLS . Omega 3: a novel treatment agent in oral submucous fibrosis: a pilot study. Journal of Oral Pathology &amp; Medicine2017;46(6):439-42. [DOI: 10.1111/jop.12542]">Raizada 2017</a>; <a href="./references#CD007156-bbs2-0090" title="RaizadaMK , SableDM . Clinical assessment of efficacy of omega 3 in oral submucous fibrosis patients – a randomized controlled trial. Asian Pacific Journal of Cancer Prevention2022;23(4):1185-92. ">Raizada 2022</a>; <a href="./references#CD007156-bbs2-0091" title="RizviD , AbidiA , FaizSM , HasanR , ThadaniA . Efficacy of curcumin gel and tulsi gel in oral submucous fibrosis. National Journal of Physiology, Pharmacy and Pharmacology2019;9(4):343-8. ">Rizvi 2019</a>; <a href="./references#CD007156-bbs2-0092" title="SaalimM , SansareK , AliIK , SonawaneH , SinglaN , VangaK , et al. Efficacy of betamethasone, hyaluronidase and its combination on mouth opening, burning sensation and QOL in patients with OSF. Journal of Oral Biology and Craniofacial Research2020;10(4):492-7. ">Saalim 2020</a>; <a href="./references#CD007156-bbs2-0093" title="SadaksharamJ , MahalingamS . Evaluation of oral pentoxifylline in the management of oral submucous fibrosis – an ultrasonographic study. Contemporary Clinical Dentistry2017;8(2):200-4. ">Sadaksharam 2017</a>; <a href="./references#CD007156-bbs2-0094" title="SaranG , UmapathyD , MisraN , ChannaiahSG , SinghP , SrivastavaS , et al. A comparative study to evaluate the efficacy of lycopene and curcumin in oral submucous fibrosis patients: a randomized clinical trial. Indian Journal of Dental Research2018;29(3):303-12. ">Saran 2018</a>; <a href="./references#CD007156-bbs2-0095" title="SelvamNP , DayanandAA . Lycopene in the management of oral submucous fibrosis. Asian Journal of Pharmaceutical and Clinical Research2013;6(3):58-61. ">Selvam 2013</a>; <a href="./references#CD007156-bbs2-0096" title="ShamsS , TariqU , SoomroSP , SultanD , AhmedK , SiyalZH , et al. Assessment between aloe vera gel and intralesional hydrocortisone in the management of stage II oral submucous fibrosis. Pakistan Journal of Medical &amp; Health Sciences2022;16(4):637-9. ">Shams 2022</a>; <a href="./references#CD007156-bbs2-0097" title="ShandilyaS , MohantyS , SharmaP , ChaudharyZ , KohliS , KumarRD . Effect of botulinum toxin-A on pain and mouth opening following surgical intervention in oral submucous fibrosis – a controlled clinical trial. Journal of Cranio-maxillo-facial Surgery2021;49(8):675-81. ">Shandilya 2021</a>; <a href="./references#CD007156-bbs2-0101" title="SinghN , HebbaleM , MhapuskarA , Ul NisaS , ThopteS , SinghS . Effectiveness of aloe vera and antioxidant along with physiotherapy in the management of oral submucous fibrosis. Journal of Contemporary Dental Practice2016;17(1):78-84. ">Singh 2016a</a>; <a href="./references#CD007156-bbs2-0103" title="SinghG , MishraM , GaurMA , SrivastavaA , ShuklaB , DasG . Collagen membrane over buccal fat pad versus buccal fat pad in management of oral submucous fibrosis: a comparative prospective study. Journal of Maxillofacial &amp; Oral Surgery2018;17(4):482-7. ">Singh 2018</a>; <a href="./references#CD007156-bbs2-0104" title="SrivastavaR , KunduA , PradhanD , JyotiB , ChokotiyaH , ParasharP . A comparative study to evaluate the efficacy of curcumin lozenges (TurmNova®) and intralesional corticosteroids with hyaluronidase in management of oral submucous fibrosis. Journal of Contemporary Dental Practice2021;22(7):751-5. ">Srivastava 2021</a>; <a href="./references#CD007156-bbs2-0106" title="TpB , GopinathanA , VargheseM , RaghavanR , VmMN , PiusA . Evaluation of therapeutic efficacy of different treatment modalities in oral submucous fibrosis: a comparative study. Journal of Contemporary Dental Practice2019;20(3):390-4. ">Tp 2019</a>); 36 studies as they were not, or were unlikely to be, RCTs (<a href="./references#CD007156-bbs2-0031" title="AgarwalM , GuptaDK , TiwariAD . Extended nasolabial flaps in the management of oral submucous fibrosis. Journal of Maxillofacial &amp; Oral Surgery2011;10(3):216-9. ">Agarwal 2011</a>; <a href="./references#CD007156-bbs2-0032" title="AgrawalD , PathakR , NewaskarV , IdreesF , WaskleR . A comparative clinical evaluation of the buccal fat pad and extended nasolabial flap in the reconstruction of the surgical defect in oral submucous fibrosis patients. Journal of Oral and Maxillofacial Surgery2018;76(3):676.e1-e5. ">Agrawal 2018</a>; <a href="./references#CD007156-bbs2-0034" title="AngadiPV . Little evidence that current interventions can benefit patients with OSMF. Evidence-based Dentistry2011;12(2):43. ">Angadi 2011</a>; <a href="./references#CD007156-bbs2-0036" title="AraSA , MuddaJA , LingappaA , RaoP . Research on curcumin: a meta-analysis of potentially malignant disorders. Journal of Cancer Research and Therapeutics2016;12(1):175-81. ">Ara 2016</a>; <a href="./references#CD007156-bbs2-0037" title="AwanKH , PatilS , HabibSR , PejcicA , ZainRB . Evaluation of medicinal interventions for the management of oral submucous fibrosis: a systematic review of the literature. Journal of Contemporary Dental Practice2014;15(6):812-7. ">Awan 2014</a>; <a href="./references#CD007156-bbs2-0038" title="AzizSR . Lack of reliable evidence for oral submucous fibrosis treatments. Evidence-based Dentistry2009;10(1):8-9. ">Aziz 2009</a>; <a href="./references#CD007156-bbs2-0039" title="BandeCR , DatarkarA , KhareN . Extended nasolabial flap compared with the platysma myocutaneous muscle flap for reconstruction of intraoral defects after release of oral submucous fibrosis: a comparative study. British Journal of Oral &amp; Maxillofacial Surgery2013;51(1):37-40. ">Bande 2013</a>; <a href="./references#CD007156-bbs2-0040" title="BandeC , DawaneP , GuptaMK , GawandeM , RodeV . Immediate versus delayed aggressive physical therapy following buccal fat pad interposition in oral submucous fibrosis-a prospective study in Central India. Oral and Maxillofacial Surgery2016;20(4):397-403. [DOI: 10.1007/s10006-016-0580-3]">Bande 2016</a>; <a href="./references#CD007156-bbs2-0043" title="BohraA , MaheswariTU , HarshA , GargA . Black turmeric and aloe vera in the management of oral submucous fibrosis: a prospective clinical study. Asian Pacific Journal of Cancer Prevention2021;22(12):3941. ">Bohra 2021</a>; <a href="./references#CD007156-bbs2-0044" title="BorleRM , NimonkarPV , RajanR . Extended nasolabial flaps in the management of oral submucous fibrosis. British Journal of Oral &amp; Maxillofacial Surgery2009;47(5):382-5. [DOI: 10.1016/j.bjoms.2008.08.019]">Borle 2009</a>; <a href="./references#CD007156-bbs2-0047" title="CholeRH , GondivkarSM , GadbailAR , BalsarafS , ChaudharyS , DhoreSV , et al. Review of drug treatment of oral submucous fibrosis. Oral Oncology2012;48(5):393-8. [DOI: 10.1016/j.oraloncology.2011.11.021]">Chole 2012</a>; <a href="./references#CD007156-bbs2-0054" title="GuptaD , SharmaSC . Oral submucous fibrosis: a new treatment regimen. Journal of Oral &amp; Maxillofacial Surgery1988;46(10):830-3. ">Gupta 1988</a>; <a href="./references#CD007156-bbs2-0057" title="IdreesF , PatelP , NewaskarV , AgrawalD . Surgical defect coverage in oral submucous fibrosis patients with single-stage extended nasolabial flap. Oral and Maxillofacial Surgery2016;20(4):411-5. ">Idrees 2016</a>; <a href="./references#CD007156-bbs2-0059" title="JiangX , HuJ . Drug treatment of oral submucous fibrosis: a review of the literature. Journal of Oral and Maxillofacial Surgery2009;67(7):1510-5. ">Jiang 2009</a>; <a href="./references#CD007156-bbs2-0061" title="JohnyJ , BhagvandasSC , MohanSP , PunathilS , MoyinS , BhaskaranMK . Comparison of efficacy of lycopene and lycopene-hyaluronidase combination in the treatment of oral submucous fibrosis. Journal of Pharmacy &amp; Bioallied Sciences2019;11(6):S260-4. [DOI: 10.4103/JPBS.JPBS_6_19]">Johny 2019</a>; <a href="./references#CD007156-bbs2-0062" title="KakarPK , PuriRK , VenkatachalamVP . Oral submucous fibrosis: treatment with hyalase. Journal of Laryngology &amp; Otology1985;99(1):57-9. ">Kakar 1985</a>; <a href="./references#CD007156-bbs2-0063" title="KamathVV . Surgical interventions in oral submucous fibrosis: a systematic analysis of the literature. Journal of Oral and Maxillofacial Surgery2014;14(3):521-31. [DOI: 10.1007/s12663-014-0639-3]">Kamath 2014</a>; <a href="./references#CD007156-bbs2-0065" title="KaremoreTV , MotwaniM . Evaluation of the effect of newer antioxidant lycopene in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2012;23(4):524-8. [DOI: 10.4103/0970-9290.104964]">Karemore 2012</a>; <a href="./references#CD007156-bbs2-0066" title="KerrAR , WarnakulasuriyaS , MighellAJ , DietrichT , NasserM , RimalJ , et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Diseases2011;17(Suppl 1):42-57. [DOI: 10.1111/j.1601-0825.2011.01791.x]">Kerr 2011</a>; <a href="./references#CD007156-bbs2-0069" title="LambadeP , DawaneP , ThoratP . Oral submucous fibrosis – a treatment protocol based on clinical study of 100 patients in central India. Oral and Maxillofacial Surgery2015;19(2):201-7. ">Lambade 2015</a>; <a href="./references#CD007156-bbs2-0072" title="LiuJ , ChenF , WeiZ , QiuM , LiZ , DanH , et al. Evaluating the efficacy of pentoxifylline in the treatment of oral submucous fibrosis: a meta-analysis. Oral Diseases2017;24(5):706-16. [DOI: 10.1111/odi.12715]">Liu 2017</a>; <a href="./references#CD007156-bbs2-0073" title="LuC , JianX . Efficacy for combined injection of salvizanolic acid B with triamcinolone acetonide on the treatment of the soft palate with oral submucous fibrosis. Zhong Nan Da Xue Xue Bao Yi Xue Ban [Journal of Central South University (Medical Sciences)]2019;44(7):801-4. ">Lu 2019</a>; <a href="./references#CD007156-bbs2-0075" title="MehrotraD , PradhanR , GuptaS . Retrospective comparison of surgical treatment modalities in 100 patients with oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology and Endodontics2009;107(3):e1-10. ">Mehrotra 2009</a>; <a href="./references#CD007156-bbs2-0080" title="PardeshiP , PadhyeM , MandlikG , MehtaP , VijK , MadiwaleG , et al. Clinical evaluation of nasolabial flap &amp; buccal fat pad graft for surgical treatment of oral submucous fibrosis-a randomized clinical trial on 50 patients in Indian population. International Journal of Oral and Maxillofacial Surgery2015;44(Suppl 1):e121-2. ">Pardeshi 2015</a>; <a href="./references#CD007156-bbs2-0083" title='PentapatiKC , GadicherlaS , SmritiK . "A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis" – a commentary. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2016;122(6):784. [DOI: 10.1016/j.oooo.2016.06.098]'>Pentapati 2016</a>; <a href="./references#CD007156-bbs2-0084" title='PentapatiKC , GadicherlaS , SmritiK . "Clinicobiochemical evaluation of turmeric with black pepper and Nigella sativa in management of oral submucous fibrosis-a double-blind, randomized preliminary study" – a commentary. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2017;123(6):737. '>Pentapati 2017</a>; <a href="./references#CD007156-bbs2-0086" title="PipaliaPR , AnnigeriRG , MehtaR , JainN . Response to &quot;Commentary on 'Clinicobiochemical evaluation of turmeric with black pepper and nigella sativa in management of oral submucous fibrosis-a double-blind, randomized preliminary study'&quot;. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2017;123(6):737-8. ">Pipalia 2017</a>; <a href="./references#CD007156-bbs2-0087" title="RaiA , DatarkarA , RaiM . Is buccal fat pad a better option than nasolabial flap for reconstruction of intraoral defects after surgical release of fibrous bands in patients with oral submucous fibrosis? A pilot study: a protocol for the management of oral submucous fibrosis. Journal of Cranio-maxillo-facial Surgery2014;42(5):e111-6. ">Rai 2014</a>; <a href="./references#CD007156-bbs2-0098" title="SharmaR , ThapliyalGK , SinhaR , MenonPS . Use of buccal fat pad for treatment of oral submucous fibrosis. Journal of Oral and Maxillofacial Surgery2012;70(1):228-32. ">Sharma 2012</a>; <a href="./references#CD007156-bbs2-0099" title="ShettyP , ShenaiP , ChatraL , RaoPK . Efficacy of spirulina as an antioxidant adjuvant to corticosteroid injection in management of oral submucous fibrosis. Indian Journal of Dental Research2013;24(3):347-50. [DOI: 10.4103/0970-9290.118001]">Shetty 2013</a>; <a href="./references#CD007156-bbs2-0100" title="SinghV , MohammadS , PantAP , SaimbiCS , SrivastavaR . Therapeutic interventions in oral submucous fibrosis: an experimental and clinical study. Journal of Maxillofacial &amp; Oral Surgery2015;14(2):278-90. ">Singh 2015</a>; <a href="./references#CD007156-bbs2-0102" title="SinghP , PandeyA , SinghA , AhujaT , SharmaS , BhagaliaSR , et al. Efficacy of intralesional placental extract, dexamethasone and hyaluronidase in treatment of oral submucous fibrosis: a comparative study. JK Practitioner2016;21(1-2):29-34. ">Singh 2016b</a>; <a href="./references#CD007156-bbs2-0105" title="TaiYS , LiuBY , WangJT , SunA , KwanHW , ChiangCP . Oral administration of milk from cows immunized with human intestinal bacteria leads to significant improvements of symptoms and signs in patients with oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2001;30(10):618-25. ">Tai 2001</a>; <a href="./references#CD007156-bbs2-0107" title="VibhaS , RoopG . Evaluation of herbal preparation in management of oral submucous fibrosis. International Journal of Oral and Maxillofacial Surgery2019;48(Suppl 1):162. ">Vibha 2019</a>; <a href="./references#CD007156-bbs2-0108" title="WarnakulasuriyaS , KerrAR . Oral submucous fibrosis: a review of the current management and possible directions for novel therapies. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2016;122(2):232-41. [DOI: 10.1016/j.oooo.2016.02.020]">Warnakulasuriya 2016</a>; <a href="./references#CD007156-bbs2-0109" title="WollinaU , VermaSB , AliFM , PatilK . Oral submucous fibrosis: an update. Clinical, Cosmetic and Investigational Dermatology2015;8:193-204. [DOI: 10.2147/CCID.S80576]">Wollina 2015</a>); two studies that did not measure outcomes relevant to this review (<a href="./references#CD007156-bbs2-0068" title="KrishnamoorthyB , KhanM . Management of oral submucous fibrosis by two different drug regimens: a comparative study. Dental Research Journal2013;10(4):527-32. ">Krishnamoorthy 2013</a>; <a href="./references#CD007156-bbs2-0074" title="MathaiP , AndradeN , KamramchandaniJ , AggarwalN . The ideal biological cover in oral submucous fibrosis. International Journal of Oral and Maxillofacial Surgery2017;46(1):146. [DOI: 10.1016/j.ijom.2017.02.505]">Mathai 2017</a>); one study that did not have the full text available (<a href="./references#CD007156-bbs2-0058" title="JainRK . Oral submucous fibrosis – aetiopathogenesis and management. In: 2nd SAARC ENT Congress; 2000 May 24-27; Kathmandu, Nepal. 27/05/2000. ">Jain 2000</a>); and one study that did not distinguish participants with OSF from those with oral cancer (<a href="./references#CD007156-bbs2-0071" title="LiYH , ChangWC , ChiangTE , LinCS , ChenYW . Mouth-opening device as a treatment modality in trismus patients with head and neck cancer and oral submucous fibrosis: a prospective study. Clinical Oral Investigations2018;23(1):469-76. ">Li 2018</a>). </p> </section> <section id="CD007156-sec-0058"> <h4 class="title">Studies awaiting classification</h4> <p>Three studies are awaiting classification (<a href="./references#CD007156-bbs2-0110" title="AlamS , AliI , GiriKY , GokkulakrishnanS , NatuSS , FaisalM , et al. Efficacy of aloe vera gel as an adjuvant treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;116(6):717-24. [DOI: 10.1016/j.oooo.2013.08.003]">Alam 2013</a>; <a href="./references#CD007156-bbs2-0111" title="CTRI/2022/03/041108. Use of analgesics in the treatment of oral sub mucous fibrosis. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2022/03/041108 (first received 15 March 2022). ">CTRI/2022/03/041108</a>; <a href="./references#CD007156-bbs2-0112" title="WuHL , LiJM . Curative effect discussion of integrated Chinese and western medicine in treatment of oral submucous fibrosis. Chinese Community Doctors [zhong guo she qu yi shi]2015;31(32):75-6. ">Wu 2015</a>). </p> </section> <section id="CD007156-sec-0059"> <h4 class="title">Ongoing studies</h4> <p>We identified eight ongoing trials, which may be included in future versions of this review (<a href="./references#CD007156-bbs2-0113" title="CTRI/2012/02/002437. Comparison of steroid releasing patch and steroid injections for oral submucous fibrosis [Comparison of the efficacy of topically applied mucosal patch with betamethasone and intralesional betamethasone in oral submucous fibrosis – a clinical study]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2012/02/002437 (first received 22 February 2012). ">CTRI201202002437</a>; <a href="./references#CD007156-bbs2-0114" title="CTRI/2013/05/003609. Exercise device to increase mouth opening in reduced mouth opening conditions [Evaluation of clinical efficacy of a new mouth-exercising device in association with local ointment application, intra-lesional drug administration and surgical treatment for oral submucous fibrosis – MEDCT]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2013/05/003609 (first received 3 May 2013). ">CTRI201305003609</a>; <a href="./references#CD007156-bbs2-0115" title="CTRI/2015/04/005696. A clinical trial of betamethasone in OSF [A randomised control trial of the corticosteroids in OSF]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2015/04/005696 (first received 13 April 2015). ">CTRI201504005696</a>; <a href="./references#CD007156-bbs2-0116" title="CTRI/2017/01/007732. Effect of two drugs for treatment of oral submucous fibrosis [Pre and post treatment expression of p53, iNOS and TGF in potentially malignant oral disorders]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2017/01/007732 (first received 20 January 2017). ">CTRI201701007732</a>; <a href="./references#CD007156-bbs2-0117" title="CTRI/2017/09/009666. Comparison of aloe vera gel and curcumin gel in oral submucous fibrosis [A randomised open label parallel study to compare the safety and efficacy of aloe vera gel and curcumin gel as add on therapy in patients of oral submucous fibrosis]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2017/09/009666 (first received 6 September 2017). ">CTRI201709009666</a>; <a href="./references#CD007156-bbs2-0118" title="CTRI/2017/09/009674. Effect of two drugs in treatment of oral submucous fibrosis [Clinical correlation and expression of Zeb1, Twist and E-cadherin in patients with oral submucous fibrosis and oral cancer]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2017/09/009674 (first received 6 September 2017). ">CTRI201709009674</a>; <a href="./references#CD007156-bbs2-0119" title="CTRI/2018/04/013147. Comparison of different treatment options in oral lichen planus and oral submucous fibrosis [Correlation of clinical stage and expression of ALDH1, ALK1 and CALR with response to treatment in OSMF and OL]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2018/04/013147 (first received 10 April 2018). ">CTRI201804013147</a>; <a href="./references#CD007156-bbs2-0120" title="CTRI/2018/04/013285. Efficacy of antioxidants in the management of oral submucous fibrosis [Efficacy of lycopene versus lycopene and curcumin in the management of oral submucous fibrosis a randomized clinical trial]. trialsearch.who.int/Trial2.aspx?TrialID=CTRI/2018/04/013285 (first received 16 April 2018). ">CTRI201804013285</a>). </p> </section> </section> <section id="CD007156-sec-0060"> <h3 class="title">Risk of bias in included studies</h3> <p>We present details of the assessment of the risk of bias for each included study in the <a href="./references#CD007156-sec-0160" title="">Characteristics of included studies</a> table, <a href="#CD007156-fig-0002">Figure 2</a>, and <a href="#CD007156-fig-0003">Figure 3</a>. </p> <div class="figure" id="CD007156-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007156-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <div class="figure" id="CD007156-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007156-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <section id="CD007156-sec-0061"> <h4 class="title">Overall risk of bias</h4> <p>One study was at low overall risk of bias (<a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>), five were at unclear overall risk of bias (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>), and the remaining 24 studies were at high overall risk of bias due to inadequate randomisation, allocation concealment, blinding, attrition bias or selective reporting (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). </p> </section> <section id="CD007156-sec-0062"> <h4 class="title">Allocation</h4> <p>We considered the method of randomisation adequate in both of its components (sequence generation and allocation concealment) in three trials (<a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>). In two trials, sequence generation was adequate but allocation concealment was at high risk of bias (<a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>). In six trials, sequence generation was adequate but allocation concealment unclear (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). Sequence generation and allocation concealment were both at high risk of bias for one trial (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>). The remaining 18 trials had unclear sequence generation and allocation concealment (<a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>). </p> </section> <section id="CD007156-sec-0063"> <h4 class="title">Blinding</h4> <section id="CD007156-sec-0064"> <h5 class="title">Performance bias</h5> <p>We judged eight trials at low risk of performance bias, as both participants and personnel were blinded (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). </p> <p>We judged 20 trials at high risk of performance bias (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>), and two studies as unclear (<a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>). </p> </section> <section id="CD007156-sec-0065"> <h5 class="title">Detection bias</h5> <section id="CD007156-sec-0066"> <h6 class="title">Mouth opening</h6> <p>All included studies measured mouth opening and all but one reported interincisal distance in millimetres as a measure of mouth opening. We judged studies using this objective measure to be at low risk of detection bias as it was unlikely to be influenced by lack of blinding. </p> </section> <section id="CD007156-sec-0067"> <h6 class="title">Burning sensation</h6> <p>Outcome assessors and participants were blinded when assessing burning sensation in nine studies, resulting in a low risk of bias judgement (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). Assessors were not blinded in 13 studies resulting in a high risk of bias judgement (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). Eight studies did not assess burning sensation (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>). </p> </section> </section> </section> <section id="CD007156-sec-0068"> <h4 class="title">Incomplete outcome data</h4> <p>We judged 19 trials at low risk of attrition bias since all enrolled participants completed the study, or the number of participants lost was unlikely to have had a significant impact on the intervention effect estimate (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>). No intention‐to‐treat analyses were performed. </p> <p>We judged three trials at high risk of attrition bias where the rate of dropouts was higher than 20% (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>). A further trial was at high risk of bias as the attrition was very imbalanced between groups (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>). </p> <p>Seven trials did not report the number of participants completing treatment and so were at unclear risk of attrition bias (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). </p> </section> <section id="CD007156-sec-0069"> <h4 class="title">Selective reporting</h4> <p>We judged 21 trials at low risk of reporting bias since all planned outcomes were reported (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). </p> <p>Nine studies reported one or more outcomes of interest incompletely or in a way that did not allow adequate interpretation and were at high risk of bias (<a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>). </p> </section> <section id="CD007156-sec-0070"> <h4 class="title">Other potential sources of bias</h4> <p>One study did not report any relevant baseline group characteristics and was judged at unclear risk of other bias (<a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>). The remaining studies were at low risk of other bias. </p> </section> </section> <section id="CD007156-sec-0071"> <h3 class="title" id="CD007156-sec-0071">Effects of interventions</h3> <p>See: <a href="./full#CD007156-tbl-0001"><b>Summary of findings 1</b> Any intervention versus no active treatment or placebo for managing oral submucous fibrosis</a> </p> <section id="CD007156-sec-0072"> <h4 class="title">Any intervention versus placebo or no active treatment</h4> <p>We considered trials comparing any intervention to placebo or no active treatment (not including habit cessation or jaw exercises if they were part of standard care) to be our main results because there is no established standard of care for OSF. </p> <section id="CD007156-sec-0073"> <h5 class="title">Participant‐reported resumption of normal eating, chewing and speech</h5> <p>No studies reported participant‐reported resumption of normal eating, chewing and speech at any time point. Four studies did report a proxy measure – difficulty in speech and swallowing (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>). The four studies reported these as frequency of presence or absence of 'difficulty'. This method of reporting subjective outcomes is not validated and cannot differentiate between degrees of improvement that might represent significant functional gains to study participants; however, for completeness, we present the results. </p> <p>A summary of these studies is reported in <a href="#CD007156-tbl-0003">Table 2</a>. </p> </section> <section id="CD007156-sec-0074"> <h5 class="title">Maximal mouth opening (interincisal distance (mm))</h5> <p>Of the placebo‐controlled trials, we identified six subgroups based on the putative mechanism of action of the interventions. </p> <section id="CD007156-sec-0075"> <h6 class="title">Less than three months' follow‐up</h6> <p>Four study subgroups reported outcomes at follow‐up of less than three months (<a href="./references#CD007156-fig-0004" title="">Analysis 1.1</a>). </p> <p>Two trials with 520 participants compared antioxidants (Oxitard and lycopene) with placebo (<a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>). Antioxidants may increase interincisal distance slightly (MD 3.11 mm, 95% CI 0.46 to 5.77; low‐certainty evidence). There was considerable heterogeneity between these studies (I<sup>2</sup> = 96%). We downgraded the certainty of the evidence due to high risk of bias (one level) and inconsistency of findings (one level). </p> <p>One trial with 106 participants compared pentoxifylline versus placebo (<a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>). Pentoxifylline may increase interincisal distance slightly (MD 1.80 mm, 95% CI 1.02 to 2.58; low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (one level). </p> <p>Two trials with 85 participants compared vasodilators (isoxsuprine and xanthinol nicotinate) with placebo (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a> – two arms of a three‐arm trial; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). We are uncertain if vasodilators reduce or increase interincisal distance (MD 2.51 mm, 95% CI −0.99 to 6.01; very low‐certainty evidence). There was no heterogeneity (I<sup>2</sup> = 0%). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>One trial compared intralesional dexamethasone injections to placebo injections (25 participants) <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>. The trial included a third arm not used in this analysis. We are uncertain if dexamethasone injections reduce or increase interincisal distance (MD −1.80 mm, 95% CI −6.30 to 2.70; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0076"> <h6 class="title">Three to six months' follow‐up</h6> <p>Six study subgroups reported outcomes at follow‐up of three to six months (<a href="./references#CD007156-fig-0006" title="">Analysis 2.1</a>). </p> <p>Three trials with 620 participants compared antioxidants with placebo (curcumin, Oxitard and lycopene) (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>). Antioxidants probably increase interincisal distance slightly (MD 8.83 mm, 95% CI 8.22 to 9.45; moderate‐certainty evidence). There was no heterogeneity (I<sup>2</sup> = 0). We downgraded the certainty of the evidence due to high risk of bias (one level). </p> <p>Two trials with 136 participants evaluated pentoxifylline. One trial compared pentoxifylline with placebo (<a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>). <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a> compared pentoxifylline plus usual care (included intralesional corticosteroid, hyaluronidase and placentrix injections, along with local heat therapy and mouth stretching exercises). We are uncertain whether pentoxifylline increases or decreases interincisal distance (MD −0.15 mm, 95% CI −5.04 to 4.74; very low‐certainty evidence). There was considerable heterogeneity within the subgroup (I<sup>2</sup> = 92%). We downgraded the certainty of the evidence due to high risk of bias (one level), inconsistency of findings (one level) and imprecision (one level). </p> <p>We were able to compare two arms of a three‐arm trial, with 25 participants between these two arms (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>). These compared intralesional dexamethasone injections to placebo injections. We are uncertain whether intralesional dexamethasone injections increase or decrease interincisal distance (MD −2.10 mm, 95% CI −6.77 to 2.57; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>Two trials with 85 participants compared vasodilators (isoxsuprine and xanthinol nicotinate) with placebo (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). We are uncertain whether vasodilators increase or decrease interincisal distance (MD 4.04 mm, 95% CI −1.93 to 10.02; very low‐certainty evidence). There was also substantial heterogeneity (I<sup>2</sup> = 61%). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>We were able to compare two arms of a three‐arm trial, with 12 participants between these two arms (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>). These arms compared hydrocortisone plus hyaluronidase with placebo. We are uncertain whether hydrocortisone plus hyaluronidase increases or decreases interincisal distance (MD −4.88 mm, 95% CI −12.87 to 3.11; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>We were able to compare two arms of a three‐arm trial, with 24 participants between these two arms (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>). These arms compared physiotherapy with no active treatment. We are uncertain whether physiotherapy increases or decreases interincisal distance (MD 0.50 mm, 95% CI −7.72 to 8.72; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0077"> <h6 class="title">More than six months' follow‐up</h6> <p>One three‐arm trial with 90 participants compared two antioxidants (curcumin, lycopene) versus placebo (<a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-fig-0012" title="">Analysis 3.1</a>). We combined the antioxidant arms for analysis. Antioxidants may make no difference to interincisal distance at six months' follow‐up or greater (MD −1.41 mm, 95% CI −5.74 to 2.92; low‐certainty evidence). We downgraded the certainty of the evidence due to imprecision (two levels). </p> </section> </section> <section id="CD007156-sec-0078"> <h5 class="title">Burning sensation (VAS 0 to 100 scale)</h5> <p>Four study subgroups reported burning sensation. Of the trials above that reported interincisal distance, only one did not report burning sensation (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>). <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> did not report burning sensation using a validated scale and, therefore, was not included in this analysis. </p> <section id="CD007156-sec-0079"> <h6 class="title">Less than three months' follow‐up</h6> <p>Three study subgroups reported outcomes at follow‐up of less than three months (<a href="./references#CD007156-fig-0005" title="">Analysis 1.2</a>). </p> <p>One trial with 400 participants compared an antioxidant (lycopene) with placebo (<a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>). Antioxidants probably reduce burning sensation VAS scores (MD −30.92 mm, 95% CI −31.57 to −30.27; moderate‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level). </p> <p>Two trials with 85 participants compared vasodilators (isoxuprine and xanthinol nicotinate) with placebo (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a> – two arms of a three‐arm trial; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). We are uncertain whether vasodilators reduce burning sensation VAS scores (MD −38.79 mm, 95% CI −52.06 to −25.53; very low‐certainty evidence). There was substantial heterogeneity detected within this subgroup (I<sup>2</sup> = 73%). We downgraded the certainty of the evidence due to high risk of bias (one level), inconsistency (one level) and imprecision (one level). </p> <p>We were able to compare two arms of a three‐arm trial with 25 participants between these two arms (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>). These arms compared intralesional dexamethasone injections to placebo injections. We are uncertain whether intralesional dexamethasone injections reduce burning sensation VAS scores (MD −52.00 mm, 95% CI −62.04 to −41.96; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0080"> <h6 class="title">Three to six months' follow‐up</h6> <p>There were four study subgroups that reported outcomes at follow‐up of three to six months (<a href="./references#CD007156-fig-0007" title="">Analysis 2.2</a>), one of which compared the intervention to 'usual care' (<a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>). </p> <p>Two trials with 500 participants compared antioxidants with placebo (curcumin and lycopene) (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>). Antioxidants probably reduce burning sensation VAS scores (MD −70.82 mm, 95% CI −94.39 to −47.25; moderate‐certainty evidence). There was considerable heterogeneity (I<sup>2</sup> = 99%). We downgraded the certainty of the evidence due to high risk of bias (one level); we did not downgrade for heterogeneity as both trials found a clear benefit from the intervention. </p> <p>One trial with 30 participants compared pentoxifylline tablets with usual care (<a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>). We are uncertain whether pentoxifylline increases or reduces burning sensation VAS scores (MD −7.00 mm, 95% CI −28.8 to 42.8; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>Two trials with 85 participants compared vasodilators (isoxsuprine and xanthinol nicotinate) with placebo (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a> – two arms of a three‐arm trial; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). We are uncertain whether vasodilators reduce burning sensation VAS scores (MD −51.02 mm, 95% CI −72.85 to −29.20; very low‐certainty evidence). There was considerable heterogeneity within this subgroup (I<sup>2</sup> = 91%). We downgraded the certainty of the evidence due to high risk of bias (one level), inconsistency (one level) and imprecision (one level). </p> <p>We were able to compare two arms of a three‐arm trial, with 25 participants between these two arms (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>). These arms compared intralesional dexamethasone injections to placebo injections. We are uncertain whether intralesional dexamethasone injections reduce burning sensation VAS scores (MD −46.00 mm, 95% CI −53.44 to −38.56; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0081"> <h6 class="title">More than six months' follow‐up</h6> <p>One three‐arm trial with 90 participants compared antioxidants (curcumin or lycopene) versus placebo (<a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-fig-0013" title="">Analysis 3.2</a>). We combined the antioxidant arms for analysis. Antioxidants probably reduce burning sensation VAS scores (MD −27.60 mm, 95% CI −36.21 to −18.99; moderate‐certainty evidence). We downgraded the certainty of the evidence due to imprecision (one level). </p> </section> </section> <section id="CD007156-sec-0082"> <h5 class="title">Other outcomes</h5> <p>The trials did not measure our other outcomes: range of jaw movement, quality of life, patient satisfaction, hospital admission or costs. </p> </section> </section> <section id="CD007156-sec-0083"> <h4 class="title">Head‐to‐head comparisons</h4> <p>There were 22 studies that compared different types of interventions against one another (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>; <a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>; <a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). The interventions evaluated are summarised in <a href="#CD007156-tbl-0002">Table 1</a>. </p> </section> <section id="CD007156-sec-0084"> <h4 class="title">Different types of medications</h4> <section id="CD007156-sec-0085"> <h5 class="title">Participant‐reported resumption of normal eating, chewing and speech</h5> <p>No studies reported this outcome at any time point. One study did report a proxy measure – difficulty in speech and swallowing (<a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>). It reported these as dichotomous outcomes (presence or absence of 'difficulty'). This method of reporting subjective outcomes is not validated and cannot differentiate between degrees of improvement that might represent significant functional gains to study participants; however, for completeness, we presented the results. See <a href="#CD007156-tbl-0005">Table 4</a> for a summary of these findings. </p> <div class="table" id="CD007156-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Additional outcome measure – difficulty in speech, swallowing and mouth opening</span></div> <tbody> <tr> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Intervention versus placebo comparisons</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 trials with 226 participants recorded 'difficulty in speech' using a VAS, but then reported this as a dichotomous outcome (presence/absence) (<a href="./references#CD007156-fig-0008" title="">Analysis 2.3</a>). </p> <p><a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a> included 120 participants and compared an antioxidant (Oxitard) with placebo. There was a reduction in the frequency of 'difficulty in speech' (OR 0.51, 95% CI 0.21 to 1.22). In the placebo group, there were 17 participants reporting 'difficulty in speech' compared with 10 participants in the intervention group. We judged this trial at unclear risk of bias. </p> <p><a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> included 106 participants and compared pentoxifylline with placebo. There was a reduction in the frequency of 'difficulty in speech' (OR 0.20, 95% CI 0.08 to 0.48). In the placebo group, there were 27 participants reporting 'difficulty in speech' compared with 9 participants in the intervention group. We judged this trial at high risk of bias. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 trials with 220 participants compared antioxidants (curcumin and Oxitard) with placebo (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>). There was an overall reduction in the frequency of 'difficulty in swallowing' (OR 0.24, 95% CI 0.10 to 0.60; <a href="./references#CD007156-fig-0009" title="">Analysis 2.4</a>). In the placebo groups, there were 24 participants reporting 'difficulty in swallowing' compared with 7 participants in the intervention groups. </p> <p><a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> included 106 participants and compared pentoxifylline with placebo. There was a reduction in the frequency of 'difficulty in swallowing' (OR 0.42, 95% CI 0.19 to 0.92). In the placebo group, there were 27 participants reporting 'difficulty in swallowing' compared with 16 participants in the intervention group. We judged this trial at high risk of bias. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in mouth opening</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 trial with 100 participants compared an antioxidant to placebo (curcumin) (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>). There was a reduction in the frequency of participants reporting 'difficulty in mouth opening' (OR 0.00, 95% CI 0.00 to 0.02; <a href="./references#CD007156-fig-0010" title="">Analysis 2.5</a>). In the placebo group, there were 47 participants reporting 'difficulty in mouth opening' compared with 2 in the intervention group. We judged this trial at unclear risk of bias. <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a> reported a reduction in the frequency of participants with 'intolerance to spicy food' (OR 0.02, 95% CI 0.00 to 0.43). In the placebo group, there were 14 participants reporting 'intolerance to spicy food' compared with 0 in the intervention group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Head‐to‐head comparisons</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 study with 120 participants compared Oxitard capsules with aloe vera gel (<a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>). There was a decrease in the frequency of participants reporting 'difficulty in speech' in favour of Oxitard (OR 0.32, 95% CI 0.14 to 0.76; <a href="./references#CD007156-fig-0018" title="">Analysis 5.3</a>). There were 23 participants reporting 'difficulty in speech' in the aloe vera group compared with 10 participants in the Oxitard group at 3–6 months' follow‐up. This study was at high risk of bias. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a> reported a decrease in the frequency of participants reporting 'difficulty in swallowing' in favour of Oxitard (OR 0.17, 95% CI 0.07 to 0.44; <a href="./references#CD007156-fig-0019" title="">Analysis 5.4</a>). There were 26 participants reporting 'difficulty in swallowing' in the aloe vera group compared with 7 participants in the Oxitard group at 3–6 months' follow‐up. This study was at high risk of bias. </p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CI: confidence interval; OR: odds ratio; VAS: visual analogue scale.</p> </div> </div> </section> <section id="CD007156-sec-0086"> <h5 class="title">Maximal mouth opening (interincisal distance (mm))</h5> <section id="CD007156-sec-0087"> <h6 class="title">Less than three months' follow‐up</h6> <p>Six subgroups compared different medical interventions head‐to‐head at follow‐up of less than three months (<a href="./references#CD007156-fig-0014" title="">Analysis 4.1</a>). </p> <p>Four trials with 128 participants compared intralesional steroid injections with a variety of alternative medicinal treatments. <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a> compared intralesional dexamethasone plus hyaluronidase to isoxsuprine tablets; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a> compared intralesional triamcinolone to intralesional salvianolic acid B; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a> compared intralesional betamethasone plus lycopene tablets to lycopene tablets alone; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a> compared intralesional dexamethasone plus hyaluronidase to Turmix tablets. We are uncertain whether intralesional steroid injections reduce or increase interincisal distance (MD −0.64 mm, 95% CI −2.16 to 0.89; low‐certainty evidence). There was no heterogeneity (I<sup>2</sup> = 0). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (one level). </p> <p>Two trials with 148 participants compared intralesional steroid injections plus adjunctive treatment with intralesion steroid injections alone. <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a> compared intralesional triamcinolone to intralesional triamcinolone plus salvianolic acid B; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a> compared intralesional prednisolone acetate to intralesional prednisolone acetate plus salvia miltorrhiza. We are uncertain whether intralesional steroid injections plus adjunctive treatment, compared with intralesion steroid injections alone, reduces or increases interincisal distance (MD −0.03 mm, 95% CI −2.48 to 2.43; low‐certainty evidence). There was no heterogeneity (I<sup>2</sup> = 0). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (one level). </p> <p>One trial with 30 participants compared levamisole with Antoxid tablets (<a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>). We are uncertain whether levamisole, compared with Antoxid, reduces or increases interincisal distance (MD −1.00 mm, 95% CI −7.18 to 5.18; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>One trial with 60 participants compared topical curcumin gel with topical aloe vera gel (<a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>). We are uncertain whether topical curcumin gel, compared with aloe vera gel, reduces or increases interincisal distance (MD −0.64 mm, 95% CI −3.91 to 2.63; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>One trial with 50 participants comparedspirulina with Oxitard (<a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>). Spirulina may decrease interincisal distance slightly (MD −2.60 mm, 95% CI −3.82 to −1.38; low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (one level). </p> <p>One trial with 120 participants compared Oxitard with aloe vera gel (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>). Oxitard may increase interincisal distance slightly (MD 9.40 mm, 95% CI 8.52 to 10.28; low‐certainty evidence). We downgraded the certainty of the evidence due to unclear risk of bias (one level) and imprecision (one level). </p> </section> <section id="CD007156-sec-0088"> <h6 class="title">Three to six months' follow‐up</h6> <p>We identified four subgroups comparing different medical interventions head‐to‐head after three to six months' follow‐up (<a href="./references#CD007156-fig-0016" title="">Analysis 5.1</a>). </p> <p>Three trials with 98 participants compared intralesional steroid injections with a variety of alternative medicinal treatments. The interventions and comparisons are described in the above section (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). There may be little to no difference in interincisal distance between treatments (MD −0.57 mm, 95% CI −2.34 to 1.19; low‐certainty evidence). There was no heterogeneity (I<sup>2</sup> = 0). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (one level). </p> <p>Two trials with 148 participants compared intralesional steroid injections plus adjunctive treatment with intralesion steroid injections alone (<a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a>). There may be little to no difference in interincisal distance between treatments (MD −0.85, 95% CI −3.31 to 1.61; low‐certainty evidence). There was no heterogeneity (I<sup>2</sup> = 0). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (one level). </p> <p>One trial with 40 participants compared pentoxifylline with spirulina (<a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>). Pentoxifylline may reduce interincisal distance (MD −8.00 mm, 95% CI −14.47 to −1.53; low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (one level). </p> <p>One trial with 30 participants compared levamisole with Antoxid tablets (<a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>). We are uncertain whether levamisole, compared with Antoxid, reduces or increases interincisal distance (MD −1.00 mm, 95% CI −7.18 to 5.18; very low‐certainty evidence). We downgraded the certainty of the evidence due to unclear risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0089"> <h6 class="title">More than six months' follow‐up</h6> <p>We identified two subgroups comparing medicinal treatments head‐to‐head with more than six months' follow‐up (<a href="./references#CD007156-fig-0020" title="">Analysis 6.1</a>). These subgroups each comprised two arms of the same three‐arm trial (<a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>). We are uncertain whether intralesional triamcinolone, compared with either intralesional salvianolic acid B injections or intralesional triamcinolone plus salvianolic acid B injections, reduces or increases interincisal distance (intralesional salvianolic acid B injections: MD −0.60 mm, 95% CI −3.76 to 2.56; 28 participants; very low‐certainty evidence; intralesional triamcinolone plus salvianolic acid B injections: MD −2.38 mm, 95% CI −5.64 to 0.88; 28 participants; very low‐certainty evidence). For both comparisons, we downgraded the certainty of the evidence due to unclear risk of bias (one level) and imprecision (two levels). </p> </section> </section> <section id="CD007156-sec-0090"> <h5 class="title">Burning sensation (VAS 0 to 100 scale)</h5> <section id="CD007156-sec-0091"> <h6 class="title">Less than three months' follow‐up</h6> <p>We identified four subgroups comparing different medicinal interventions head‐to‐head with less than three months' follow‐up (<a href="./references#CD007156-fig-0015" title="">Analysis 4.2</a>). </p> <p>Two trials with 58 participants compared intralesional steroid injections to different alternative medicinal treatments. The interventions and comparisons have been reported in the above section (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>). We are uncertain whether steroid injections in comparison to alternative medical treatments reduce or increase burning sensation VAS scores (MD −0.06 mm, 95% CI −10.64 to 10.52; very low‐certainty evidence). There was substantial heterogeneity within this subgroup (I<sup>2</sup> = 74%). We downgraded the certainty of the evidence due to unclear risk of bias (one level) and imprecision (two levels). </p> <p>One trial with 28 participants compared intralesional triamcinolone injections to intralesional triamcinolone plus salvianolic acid B injections (<a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>). We are uncertain whether intralesional triamcinolone injections compared to intralesional triamcinolone plus salvianolic acid B injections reduce or increase burning sensation VAS scores (MD −1.00 mm, 95% CI −10.37 to 8.37; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>One trial with 30 participants compared levamisole versus an antioxidant (<a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>). We are uncertain whether intralesional levamisole, compared with antioxidants, reduces burning sensation VAS scores (MD −9.10 mm, 95% CI −16.23 to −1.97; very low‐certainty evidence). We downgraded the certainty of the evidence due to unclear risk of bias (one level) and imprecision (two levels). </p> <p>One trial with 60 participants compared topical curcumin gel with aloe vera gel (<a href="./references#CD007156-bbs2-0022" title="RajbhojAN , KulkarniTM , SheteA , SheteM , GoreR , SapkalR . A comparative study to evaluate efficacy of curcumin and aloe vera gel along with oral physiotherapy in the management of oral submucous fibrosis: a randomized clinical trial. Asian Pacific Journal of Cancer Prevention2021;22(S1):107-12. ">Rajbhoj 2021</a>). We are uncertain whether topical curcumin gel, compared with aloe vera gel, increases burning sensation VAS scores (MD 16.00 mm, 95% CI 7.21 to 24.79; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0092"> <h6 class="title">Three to six months' follow‐up</h6> <p>We identified four subgroups comparing different medicinal interventions head‐to‐head with between three and six months' follow‐up (<a href="./references#CD007156-fig-0017" title="">Analysis 5.2</a>). </p> <p>Three trials with 98 participants compared intralesional steroid injections with a variety of alternative medicinal treatments. The interventions and comparisons are described in the above section (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>). We are uncertain whether intralesional steroid injections, compared with alternative medicinal treatments, increase or reduce burning sensation VAS scores (MD 8.61 mm, 95% CI −4.52 to 21.74; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level), imprecision (one level) and substantial heterogeneity (I<sup>2</sup> = 90%). </p> <p>We were able to compare two arms of a three‐arm trial with 28 participants between these two arms (<a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>). These arms compared intralesional triamcinolone injections with intralesional triamcinolone injections plus salvianolic acid B. We are uncertain whether intralesional triamcinolone injections, compared with intralesional triamcinolone injections plus salvianolic acid B, reduce burning sensation VAS scores (MD −16.30 mm, 95% CI −28.15 to −4.45; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>One trial with 40 participants compared pentoxifylline to spirulina tablets (<a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>). We are uncertain whether pentoxifylline, compared with spirulina, increases or reduces burning sensation VAS scores (MD 0.50 mm, 95% CI −6.60 to 7.60; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>One trial with 30 participants compared levamisole versus an antioxidant (<a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a>). We are uncertain whether levamisole, compared with antioxidant, reduces burning sensation VAS scores (MD −7.0 mm, 95% CI −13.56 to −0.44; very low‐certainty evidence). We downgraded the certainty of the evidence due to unclear risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0093"> <h6 class="title">More than six months' follow‐up</h6> <p>We identified no subgroups that reported burning sensation VAS scores at more than six months' follow‐up. </p> </section> </section> <section id="CD007156-sec-0094"> <h5 class="title">Other outcomes</h5> <p>The trials did not measure our other outcomes: range of jaw movement, quality of life, patient satisfaction, hospital admission or costs. </p> </section> </section> <section id="CD007156-sec-0095"> <h4 class="title">Different surgical techniques</h4> <section id="CD007156-sec-0096"> <h5 class="title">Maximal mouth opening (interincisal distance (mm))</h5> <section id="CD007156-sec-0097"> <h6 class="title">Less than three months' follow‐up</h6> <p>We identified two subgroups comparing surgical techniques with one another (<a href="./references#CD007156-fig-0021" title="">Analysis 7.1</a>). </p> <p>One trial with eight participants compared buccal fat pad grafts with extended nasolabial flaps (<a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>). We are uncertain if buccal fat pad grafts, compared with extended nasolabial flaps, reduce interincisal distance (MD −7.25 mm, 95% CI −14.19 to −0.31; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>One trial with 30 participants compared abdominal dermal fat grafts with nasolabial flaps (<a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>). We are uncertain if abdominal dermal fat grafts, compared with nasolabial flaps, reduce interincisal distance (MD −3.60 mm, 95% CI −5.17 to −2.03; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0098"> <h6 class="title">Three to six months' follow‐up</h6> <p>We identified two subgroups comparing surgical techniques with three to six months' follow‐up data (<a href="./references#CD007156-fig-0022" title="">Analysis 8.1</a>). </p> <p>One trial with 30 participants compared abdominal dermal fat grafts with nasolabial flaps (<a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>). We are uncertain if abdominal dermal fat grafts, compared with nasolabial flaps, reduce interincisal distance (MD −14.87 mm, 95% CI −19.93 to −9.81; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> <p>One trial with eight participants compared extended nasolabial flaps to buccal fat pad grafts (<a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>). We are uncertain if extended nasolabial flaps, compared with buccal fat pad grafts, reduce or increase interincisal distance (MD −6.00 mm, 95% CI −23.36 to 11.36; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0099"> <h6 class="title">More than six months' follow‐up</h6> <p>We identified one subgroup that reported interincisal distance at more than six months' follow‐up (<a href="./references#CD007156-fig-0023" title="">Analysis 9.1</a>). </p> <p>One trial with eight participants compared extended nasolabial flaps to buccal fat pad grafts (<a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>). We are uncertain if abdominal dermal fat grafts, compared with nasolabial flaps, reduce or increase interincisal distance (MD −6.50 mm, 95% CI −23.72 to 10.72; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> </section> <section id="CD007156-sec-0100"> <h5 class="title">Burning sensation (VAS 0 to 100 scale)</h5> <p>No studies comparing surgical modalities measured impact on burning sensation at any time point. </p> </section> <section id="CD007156-sec-0101"> <h5 class="title">Other outcomes</h5> <p>The trials did not measure our other outcomes: range of jaw movement, quality of life, patient satisfaction, hospital admission or costs. </p> </section> </section> <section id="CD007156-sec-0102"> <h4 class="title">Surgery alone compared with surgery plus adjunctive treatments</h4> <section id="CD007156-sec-0103"> <h5 class="title">Maximal mouth opening (interincisal distance (mm))</h5> <section id="CD007156-sec-0104"> <h6 class="title">Less than three months' follow‐up</h6> <p>We identified one subgroup for this comparison (<a href="./references#CD007156-fig-0024" title="">Analysis 10.1</a>). </p> <p>One trial with 10 participants compared buccal fat pad pedicle with placental extract versus buccal fat pad pedicle alone (<a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a>). We are uncertain if buccal fat pad pedicle with placental extract, compared with buccal fat pad pedicle alone, increases interincisal distance (MD 7.80 mm, 95% CI 4.90 to 10.70; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0105"> <h6 class="title">Three to six months' follow‐up</h6> <p>We found no subgroups that evaluated interincisal distance at three to six months' follow‐up for this comparison. </p> </section> <section id="CD007156-sec-0106"> <h6 class="title">More than six months' follow‐up</h6> <p>We found no subgroups that evaluated interincisal distance at more than six months for this comparison. </p> </section> </section> <section id="CD007156-sec-0107"> <h5 class="title">Burning sensation (VAS 0 to 100 scale)</h5> <p>No studies comparing surgical modalities with or without adjunctive medical intervention measured burning sensation as an outcome. </p> </section> <section id="CD007156-sec-0108"> <h5 class="title">Other outcomes</h5> <p>The trials did not measure our other outcomes: range of jaw movement, quality of life, patient satisfaction, hospital admission or costs. </p> </section> </section> <section id="CD007156-sec-0109"> <h4 class="title">Physiotherapy alone compared with physiotherapy plus adjunctive treatments</h4> <section id="CD007156-sec-0110"> <h5 class="title">Maximal mouth opening (interincisal distance (mm))</h5> <section id="CD007156-sec-0111"> <h6 class="title">Less than three months' follow‐up</h6> <p>We identified one subgroup that reported interincisal distance at less than three months' follow‐up (<a href="./references#CD007156-fig-0025" title="">Analysis 11.1</a>). </p> <p>One trial with 20 participants compared jaw opening exercises alone to ultrasound plus jaw opening exercises (<a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a>). We are uncertain if jaw opening exercises alone, compared with ultrasound plus jaw opening exercises, reduce or increase interincisal distance (MD −3.70 mm, 95% CI −11.53 to 4.13; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0112"> <h6 class="title">Three to six months' follow‐up</h6> <p>We found no subgroups that evaluated interincisal distance at three to six months' follow‐up for this comparison. </p> </section> <section id="CD007156-sec-0113"> <h6 class="title">More than six months' follow‐up</h6> <p>We found no subgroups that evaluated interincisal distance at more than six months for this comparison. </p> </section> </section> <section id="CD007156-sec-0114"> <h5 class="title">Burning sensation (VAS 0 to 100 scale)</h5> <p>No studies comparing physiotherapy alone versus physiotherapy plus adjunctive treatments measured burning sensation as an outcome. </p> </section> <section id="CD007156-sec-0115"> <h5 class="title">Other outcomes</h5> <p>The trials did not measure our other outcomes: range of jaw movement, quality of life, patient satisfaction, hospital admission or costs. </p> </section> </section> <section id="CD007156-sec-0116"> <h4 class="title">Physiotherapy compared with medication</h4> <section id="CD007156-sec-0117"> <h5 class="title">Maximal mouth opening (interincisal distance (mm))</h5> <section id="CD007156-sec-0118"> <h6 class="title">Less than three months' follow‐up</h6> <p>We identified one subgroup that reported interincisal distance at less than three months' follow‐up (<a href="./references#CD007156-fig-0026" title="">Analysis 12.1</a>). </p> <p>We were able to compare two arms of a three‐arm trial, with 20 participants, comparing tongue depressor stretches to intralesional steroid and hyaluronidase injections (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>). We are uncertain if tongue depressor stretches, compared with intralesional steroid and hyaluronidase injections, increase or reduce interincisal distance (MD 5.38 mm, 95% CI −2.24 to 13.00; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0119"> <h6 class="title">Three to six months' follow‐up</h6> <p>We found no subgroups that evaluated interincisal distance at three to six months' follow‐up for this comparison. </p> </section> <section id="CD007156-sec-0120"> <h6 class="title">More than six months' follow‐up</h6> <p>We found no subgroups that evaluated interincisal distance at more than six months for this comparison. </p> </section> </section> <section id="CD007156-sec-0121"> <h5 class="title">Burning sensation (VAS 0 to 100 scale)</h5> <p>No studies comparing physiotherapy versus medications measured burning sensation as an outcome. </p> </section> <section id="CD007156-sec-0122"> <h5 class="title">Other outcomes</h5> <p>The trials did not measure our other outcomes: range of jaw movement, quality of life, patient satisfaction, hospital admission or costs. </p> </section> </section> <section id="CD007156-sec-0123"> <h4 class="title">Surgery combined with different physiotherapy techniques</h4> <section id="CD007156-sec-0124"> <h5 class="title">Maximal mouth opening (interincisal distance (mm))</h5> <section id="CD007156-sec-0125"> <h6 class="title">Less than three months' follow‐up</h6> <p>We found no studies that evaluated interincisal distance at less than three months for this comparison. </p> </section> <section id="CD007156-sec-0126"> <h6 class="title">Three to six months' follow‐up</h6> <p>We identified one study that reported interincisal distance at three to six months' follow‐up (<a href="./references#CD007156-fig-0027" title="">Analysis 13.1</a>). </p> <p>One trial with 50 participants compared surgery plus Heister jaw opener versus surgery plus wooden tongue depressors (<a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>). We are uncertain if surgery plus Heister jaw opener, compared with surgery plus wooden tongue depressors, increases interincisal distance (MD 0.92 mm, 95% CI 0.28 to 1.56; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> <section id="CD007156-sec-0127"> <h6 class="title">Greater than six months' follow‐up</h6> <p>We identified one study that reported interincisal distance at greater than six months' follow‐up (<a href="./references#CD007156-fig-0028" title="">Analysis 14.1</a>). </p> <p>One trial with 50 participants compared surgery plus Heister jaw opener versus surgery plus wooden tongue depressors (<a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>). We are uncertain if surgery plus Heister jaw opener, compared with surgery plus wooden tongue depressors, increases interincisal distance (MD 0.60 mm, 95% CI 0.01 to 1.19; very low‐certainty evidence). We downgraded the certainty of the evidence due to high risk of bias (one level) and imprecision (two levels). </p> </section> </section> <section id="CD007156-sec-0128"> <h5 class="title">Burning sensation (VAS 0 to 100 scale)</h5> <p><a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a> measured burning sensation on a VAS, but did not fully report the results. The article stated that "regarding burning sensation, there was no significant difference among the 2 groups (p = 0.617)". </p> </section> <section id="CD007156-sec-0129"> <h5 class="title">Other outcomes</h5> <p>The trials did not measure our other outcomes: range of jaw movement, quality of life, patient satisfaction, hospital admission or costs. </p> </section> </section> <section id="CD007156-sec-0130"> <h4 class="title">Studies not included in quantitative analysis</h4> <p>We excluded seven studies from meta‐analyses as data were mis‐reported (<a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>), or not reported in a usable format (<a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>). </p> <p>Six studies reported important outcomes, such as pain; improvement in intolerance to spicy foods; and reduction in difficulty with eating, swallowing and speaking (<a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a>; <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>). <a href="#CD007156-tbl-0003">Table 2</a> and <a href="#CD007156-tbl-0004">Table 3</a> present the findings. </p> <p><a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a> was a three‐armed trial that compared intralesional betamethasone injections (90 participants) versus lycopene capsules (90 participants) versus placebo (90 participants), and reported data that appeared to show increased interincisal distance in both intervention groups compared to placebo. However, the authors reported only between‐group differences in interincisal distance with no baseline measurements and so changes in interincisal distance could not be determined. </p> <p><a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a> evaluated pentoxifylline tablets (14 participants) compared to 'multivitamins' (15 participants). They reported increased interincisal distance in the pentoxifylline group, but did not report baseline data, so changes in interincisal distance could not be determined. The authors also concluded that the intervention reduced pain. However, pain intensity evaluations were inadequately defined and obtained via "interview data", which makes interpretation of the mean scores presented difficult. </p> <p><a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a> was a three‐armed trial that compared oral lycopene (21 participants) versus oral lycopene plus intralesional betamethasone (19 participants) versus placebo (18 participants). They reported data that appeared to show an increase in interincisal distance in the two active intervention groups compared with placebo, but there was limited information provided on withdrawals and incomplete data, which meant the values presented could not be interpreted quantitatively. </p> <p><a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a> compared intralesional hydrocortisone plus hyaluronidase (50 participants) versus triamcinolone plus hyaluronidase (50 participants). They reported mouth opening as trismus presented categorically rather than as continuous data, which precluded quantitative analysis. The other outcomes reported were not relevant to this review, such as changes in histological appearance of lesions, vesicle formation and burning sensation reported on a non‐validated scale. The authors found no difference between their intervention groups for any outcomes measured. </p> <p><a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a> investigated topical aloe vera gel (10 participants) versus antioxidant capsules (10 participants). They reported a reduction in burning sensation and improvement in interincisal distance but did not report baseline data, so changes could not be determined. </p> </section> <section id="CD007156-sec-0131"> <h4 class="title">Adverse effects</h4> <p>Fifteen studies made statements regarding adverse effects. Of these, six did not encounter adverse effects of treatment (<a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a>; <a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a>; <a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a>), while nine reported adverse effects in treatment groups (<a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>; <a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>; <a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>; <a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>). </p> <p>One study reported three adverse effects, which we classified as serious based on the likelihood of extended hospital stay (<a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a>, abdominal dermal fat graft versus nasolabial flap). All three adverse effects were graft failure but no further information was provided within the report. </p> <p>There were no serious adverse events such as death or complications resulting in hospital admission reported following any of the interventions. There were mild and transient general adverse effects of systemic drug use, such as dyspepsia, abdominal pain and bloating, gastritis, and nausea, that may have been linked directly to the interventions (<a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a>; <a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a>; <a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>;<a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a>). One study reported transient peripheral flushing in 90% of participants (<a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). Three participants reported the development of oral ulceration following local and systemic interventions (<a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). There were also surgical complications such as infection, wound breakdown (<a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a>), and intraoral hair growth (<a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a>). </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD007156-sec-0132" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD007156-sec-0132"></div> <section id="CD007156-sec-0133"> <h3 class="title" id="CD007156-sec-0133">Summary of main results</h3> <p>This review assessed the effectiveness of interventions in the management of symptoms and sequelae of OSF. We identified resumption of normal function (e.g. eating, chewing, speech) as being most likely to impact daily activities and, therefore, of the highest priority. We also selected measurement of mouth opening (by interincisal distance) as a proxy measure of function, which has the advantage of being an easily quantifiable and reproducible clinical measure. Severity of burning sensation was also chosen as a frequently reported symptom by people with OSF. Secondary outcomes included quality of life measures and economic considerations associated with treatment. We did not find any studies that reported our secondary outcomes. </p> <p>This updated review included 30 studies, of which 28 were new. Most studies had methodological issues or were not reported with sufficient information to enable us to completely assess methodological rigour, which limits our confidence in their findings. We judged one trial at overall low risk of bias, five trials at unclear risk and the remaining 24 trials at high risk of bias. </p> <p>No trials reported our main outcome of interest, which was participant‐reported resumption of normal eating, chewing and speech. Twenty‐nine studies evaluated interincisal distance and 15 evaluated severity of burning sensation using a VAS. Fifteen studies made statements regarding adverse effects. One study reported adverse effects, including serious adverse effects related to surgical procedures. Eight studies reported mild and transient adverse effects of systemic drugs such as dyspepsia, abdominal pain and bloating, gastritis, and nausea. None reported serious adverse events such as death or complications resulting in hospital admission. However, participant numbers were low for each intervention and reporting was inconsistent and lacked detail, so evaluation of intervention safety is severely limited. </p> <p>We found a wide range of interventions across different trials with several different putative mechanisms of action and modes of delivery. Therefore, we categorised trials into seven broad comparisons: 'any intervention versus placebo', 'different types of medications versus one another', 'different surgical techniques versus one another', 'surgery alone versus surgery plus adjunctive treatments', 'physiotherapy alone versus physiotherapy plus adjunctive treatments', 'physiotherapy versus medications', 'surgery combined with different physiotherapy techniques'. Due to the degree of heterogeneity in interventions, we considered that pooling of subgroups within these comparisons was inappropriate. Therefore, we undertook meta‐analysis at subgroup level only. Often the rationale and clinical justification for the specific interventions and comparisons selected was scant or absent. </p> <p>None of the studies measured our main outcome 'participant‐reported resumption of normal eating, chewing and speech'. Four studies included a proxy measure that was not validated and provided dichotomous data only (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>). </p> <p>We found nine studies with usable data that compared any intervention versus placebo for the outcome of mouth opening measured by interincisal distance in millimetres (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>; <a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). Antioxidants may increase mouth opening (indicated by interincisal distance (mm)) when measured at less than three months, and probably increase mouth opening slightly at three to six months. Antioxidants may make no difference to interincisal distance at six months' follow‐up or greater. Pentoxifylline may increase mouth opening slightly at less than three months. It should be noted, however, that these results are all less than 10 mm, which could be considered the minimal change that is meaningful to someone with oral submucous fibrosis. The evidence was very uncertain for all other interventions compared to placebo or no active treatment (intralesional dexamethasone injections, pentoxifylline, hydrocortisone plus hyaluronidase, physiotherapy). </p> <p>We found six studies with usable data that compared any intervention versus placebo for the outcome of burning sensation (VAS) (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0003" title="ArakeriG , PatilS , MaddurN , RaoUS , SubashA , PatilS , et al. Long-term effectiveness of lycopene in the management of oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2020;49(8):803-8. ">Arakeri 2020</a>; <a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a>; <a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a>; <a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a>; <a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a>). Antioxidants probably reduce burning sensation VAS scores at less than three months, at three to six months and at more than six months (moderate certainty evidence). The evidence was very uncertain for the other interventions that were compared to placebo and measured burning sensation (intralesional dexamethasone, vasodilators). </p> <p>Fifteen studies reported adverse effects as an outcome. Six of these studies found no adverse effects. One study evaluating abdominal dermal fat graft reported serious adverse effects resulting in prolonged hospital stay for 3/30 participants. There were mild and transient general adverse effects of systemic drugs, such as dyspepsia, abdominal pain and bloating, gastritis, and nausea, in studies evaluating vasodilators and antioxidants in particular. In all the interventions evaluated, the effect of the interventions was small (0.5 mm to 8.83 mm of improvement). </p> <p>There is no reported MCID in burning sensation VAS scores for people with OSF. One systematic review of MCIDs in chronic pain conditions has suggested 32% relative reduction in VAS scores. As with mouth opening, this needs validating for people with OSF. We found moderate‐certainty evidence that antioxidants reduced burning sensation by 44% at less than three months; 97% at three to six months; 65% at greater than six months. </p> </section> <section id="CD007156-sec-0134"> <h3 class="title" id="CD007156-sec-0134">Overall completeness and applicability of evidence</h3> <p>In this review we presented the evidence regarding a wide variety of interventions in treating people with OSF. There is no recognised standard of care for OSF. The studies included in this review investigated the effectiveness of numerous interventions with different proposed mechanisms of action. Additionally, the 'control' groups often included a clinically active treatment and some studies used combined interventions with overlapping putative mechanisms. This confounds reliable assessment of the effectiveness of either intervention used alone. Therefore, it is difficult to make meaningful comparisons across interventions and studies. </p> <p>Due to the chronic nature of OSF and the impact of this condition on quality of life, the use of patient‐reported outcome measures (PROMs) reflecting normal daily functional activities, such as eating and speaking, is important. Most trials relied on interincisal distance (29/30 trials), with fewer trials reporting burning sensation (15/30 trials). These outcomes may not reflect functional limitations important to patients, although their assessment is straightforward to administer clinically and relatively reliable. However, only 4/30 trials reported PROMs similar to those prespecified as our primary outcome (participant‐reported resumption of normal eating, chewing and speech). These PROMs were reported in a limited manner (presence or absence of difficulties only). </p> <p>Adverse effects of treatments should be reported routinely in clinical trials but were omitted in 15/30 trials. Reporting of adverse effects for interventions such as antioxidant supplements is particularly important as these are not subject to the same rigorous safety testing as pharmaceutical products, because they are classified as nutrients by regulatory authorities (<a href="./references#CD007156-bbs2-0147" title="MaxwellSR . Antioxidant vitamin supplements. Drug Safety1999;21(4):253-66.">Maxwell 1999</a>). </p> <p>OSF is a chronic condition and any intervention should demonstrate long‐term effectiveness before being considered for routine clinical use. The longest follow‐up period identified with usable data was only nine months. As most studies appear to be evaluating interventions already being used in local clinical practice, longer‐term outcome data beyond the initial trial period should be an important consideration alongside monitoring for adverse effects/events. We found no evidence that this is being undertaken. </p> <p>Most studies did not report power calculations. Because of the small sample size in many trials, it is likely that studies were not adequately powered to detect differences in treatment if present. Additionally, such small sample sizes can lead to failure to detect rarer but important adverse effects associated with different treatment modalities. Baseline demographics of participants were often not reported, making extrapolation to other patient cohorts challenging. Failure to report baseline demographics meant that we were unable to evaluate the effectiveness of randomisation in balancing groups regarding important confounders, which is especially important in trials with small numbers of participants. </p> <p>There is no reported MCID in mouth opening for people with OSF. An absolute change of 10 mm has been suggested as the MCID in a temporomandibular joint dysfunction population (<a href="./references#CD007156-bbs2-0140" title="KaurA , RustagiN , GanesanA , NihadhaPM , KumarP , ChaudhryK . Minimal clinically important difference of mouth opening in oral submucous fibrosis patients: a retrospective study. Journal of the Korean Association of Oral and Maxillofacial Surgeons2022;48(3):167-73.">Kaur 2022</a>). This needs validating for people with OSF but is the best available estimate at present. Given the overall uncertainty of the evidence, we remain uncertain about the magnitude of the effect estimate. Similarly, there is no reported MCID in burning sensation VAS scores for people with OSF. A systematic review of MCIDs in chronic pain conditions has suggested 32% relative reduction in VAS scores. As with mouth opening, this needs validating for people with OSF. We found moderate‐certainty evidence that antioxidants reduced burning sensation by 44% at less than three months; 97% at three to six months; 65% at greater than six months. </p> <p>An important part of clinical practice is instruction in cessation of areca nut habit. Most studies included cessation advice as part of their protocol and made attempts to monitor this, but assessment of continued cessation of habit was reported inconsistently. Most protocols included advice to perform mouth stretching exercises alongside the active interventions and so most participants also received some form of physiotherapy, if informally. No trials reported compliance with these ancillary physiotherapy regimens. As most studies were unblinded or inadequately blinded, we also could not rule out the impact of performance bias leading to participants who knew they were receiving an experimental intervention being more compliant with mouth stretching exercises and habit abstinence. </p> <p>Due to the low certainty of evidence, heterogeneity of interventions and outcomes, and lack of standardised treatment protocols, it is difficult to translate the findings of this review into clinical practice. This is compounded by the use of active interventions as control groups in many studies. Therefore, we find it difficult to justify trials evaluating head‐to‐head comparisons of interventions lacking efficacy data. </p> <p>Of note, the search identified eight ongoing trials. Seven of these include head‐to‐head comparisons, with only one placebo‐controlled trial. This suggests that the findings of these studies are unlikely to meaningfully change the conclusions of this review. </p> </section> <section id="CD007156-sec-0135"> <h3 class="title" id="CD007156-sec-0135">Quality of the evidence</h3> <p>We included only RCTs in this review, which are considered the gold standard trial design to assess the effectiveness of interventions. However, this depends on the methodological rigour of the studies, which is summarised by risk of bias assessments. Only one of the included trials was at low risk of overall bias (five were unclear and 24 were high). The most common sources of bias were failure to blind participants and selective reporting. Risk of bias judgements were significantly hampered by reporting standards. Almost 25% of judgements were unclear due to insufficient information. Attempts made to clarify information with study authors were largely unsuccessful. Therefore, we consider that trials with unclear risk of bias are likely to reflect a high risk of bias. </p> </section> <section id="CD007156-sec-0136"> <h3 class="title" id="CD007156-sec-0136">Potential biases in the review process</h3> <p>Data from several studies included in this review could not be analysed quantitatively due to inadequate reporting, which prevented data extraction. This could have introduced reporting bias. Where possible, we provided a narrative description of trials with data that did not allow quantitative analysis. We attempted to minimise bias such as obtaining translations where necessary rather than excluding non‐English language papers and contacting authors by email to request missing data. The broad inclusion criteria for types of intervention resulted in a clinically heterogeneous group of trials. Therefore, we considered it was inappropriate to combine subgroups. Consequently, our analyses include small numbers of participants from few trials, which is reflected in our reduced certainty in the evidence. We used Covidence to screen and assess abstracts and full‐text papers for the 2023 update (<a href="./references#CD007156-bbs2-0129" title="Covidence. Melbourne, Australia: Veritas Health Innovation, Date accessed: 15/08/2023. Available at covidence.org.">Covidence</a>). To be included, trials had to employ both a clinical and histological diagnosis for OSF. Although this method ensures that only people with a confirmed diagnosis of OSF are included in this review, it is potentially restrictive as biopsy of suspected OSF lesions is not standard practice in all centres due to the risk of exacerbating symptoms. </p> </section> <section id="CD007156-sec-0137"> <h3 class="title" id="CD007156-sec-0137">Agreements and disagreements with other studies or reviews</h3> <p>There have been several systematic reviews of interventions to manage OSF since the first iteration of this review (<a href="./references#CD007156-bbs2-0121" title="Al-Maweri, SA. Efficacy of curcumin for management of oral submucous fibrosis: a systematic review of randomized clinical trials. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2019;127(4):300-8.">Al‐Maweri 2019a</a>; <a href="./references#CD007156-bbs2-0122" title="Al-MaweriSA , AshrafS , LingamAS , AlqutaibiA , AbdulrabS , AlaizariN , et al. Aloe vera in treatment of oral submucous fibrosis: a systematic review and meta-analysis. Journal of Oral Pathology &amp; Medicine2019;48(2):99-107.">Al‐Maweri 2019b</a>; <a href="./references#CD007156-bbs2-0127" title="AwanKH , PatilS , HabibSR , PejcicA , ZainRB . Evaluation of medicinal interventions for the management of oral submucous fibrosis: a systematic review of the literature. Journal of Contemporary Dental Practice2014;15(6):812-7.">Awan 2014</a>; <a href="./references#CD007156-bbs2-0130" title="GondivkarSM , GadbailAR , SarodeSC , GondivkarRS , PatilS , GaikwadRN , et al. Clinical efficacy of mouth exercising devices in oral submucous fibrosis: a systematic review. Journal of Oral Biology and Craniofacial Research2020;10(4):315-20.">Gondivkar 2020</a>; <a href="./references#CD007156-bbs2-0132" title="GuoJ , XieH , MaoS , LiangM , WuH . Efficacy of hyaluronidase combined with corticosteroids in treatment of oral submucous fibrosis: a meta-analysis of randomized controlled clinical trials. Journal of Oral Pathology &amp; Medicine2020;49(4):311-9.">Guo 2020a</a>; <a href="./references#CD007156-bbs2-0133" title="GuoJ , XieH , WuH , LiangM . Efficacy of lycopene in the treatment of oral submucous fibrosis: a meta-analysis of randomized controlled trials. Journal of Evidence Based Dental Practice2020;20(4):101471.">Guo 2020b</a>; <a href="./references#CD007156-bbs2-0134" title="GuoJC , XieH , WuH , TongTJ . Efficacy of curcumin in the treatment of oral submucous fibrosis: a meta-analysis. West China Journal of Stomatology2021;39(2):195-202.">Guo 2021</a>; <a href="./references#CD007156-bbs2-0135" title="GuptaN , KalaskarA , KalaskarR . Efficacy of lycopene in management of oral submucous fibrosis – a systematic review and meta-analysis. Journal of Oral Biology and Craniofacial Research2020;10(4):690-7.">Gupta 2020</a>; <a href="./references#CD007156-bbs2-0139" title="KamathVV . Surgical interventions in oral submucous fibrosis: a systematic analysis of the literature. Journal of Maxillofacial and Oral Surgery2015;14(3):521-31.">Kamath 2015</a>; <a href="./references#CD007156-bbs2-0141" title="KerrAR , WarnakulasuriyaS , MighellAJ , DietrichT , NasserM , RimalJ , et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Diseases2011;17(s1):42-57.">Kerr 2011</a>; <a href="./references#CD007156-bbs2-0149" title="MoreCB , PatilDJ , RaoNR . Medicinal management of oral submucous fibrosis in the past decade – a systematic review. Journal of Oral Biology and Craniofacial Research2020;10(4):552-68.">More 2020</a>; <a href="./references#CD007156-bbs2-0152" title="RaiA , KumarN , SharmaS , ParveenS , RasheedA . Turmeric in the management of oral submucous fibrosis: a systematic review and meta-analysis. Journal of Cancer Research and Therapeutics2021;17(2):327.">Rai 2021</a>; <a href="./references#CD007156-bbs2-0153" title="Rajesh KashyapR , ShankerKR . Herbal derivatives in the management of mouth opening in oral submucous fibrosis – a network meta-analysis. Oral Diseases2021;27(7):1606-15.">Rajesh Kashyap 2021</a>; <a href="./references#CD007156-bbs2-0157" title="XieH , GuoJ , TanB , WuH . Efficacy of Salvia miltiorrhiza injection combined with steroids in the treatment of oral submucous fibrosis: a meta-analysis of randomized controlled trials. Medicine2019;98(27):e16339.">Xie 2019</a>). </p> <p>Several reviews of medical interventions broadly mirror our findings. <a href="./references#CD007156-bbs2-0141" title="KerrAR , WarnakulasuriyaS , MighellAJ , DietrichT , NasserM , RimalJ , et al. A systematic review of medical interventions for oral submucous fibrosis and future research opportunities. Oral Diseases2011;17(s1):42-57.">Kerr 2011</a> reviewed medical interventions and found that the quality and reporting of available research made drawing specific conclusions difficult. <a href="./references#CD007156-bbs2-0149" title="MoreCB , PatilDJ , RaoNR . Medicinal management of oral submucous fibrosis in the past decade – a systematic review. Journal of Oral Biology and Craniofacial Research2020;10(4):552-68.">More 2020</a> reviewed innovations in medical management of OSF between 2011 and 2020, encompassing interventions such as steroid injections, hyaluronidase injections, curcumin tablets or gels, Oxitard tablets or pentoxifylline. No individual intervention was effective. The authors concluded that most of the studies reviewed were at high risk of bias and suggested that further high‐quality RCTs with larger sample sizes are required. <a href="./references#CD007156-bbs2-0127" title="AwanKH , PatilS , HabibSR , PejcicA , ZainRB . Evaluation of medicinal interventions for the management of oral submucous fibrosis: a systematic review of the literature. Journal of Contemporary Dental Practice2014;15(6):812-7.">Awan 2014</a> also reviewed a wide range of medical interventions to manage OSF; they reported mostly controlled clinical trials and concluded that the evidence was limited to support drug treatments and further high‐quality RCTs are needed. Each review also concluded there is a need for more robust research performed with methodological rigour. </p> <p>Of the reviews examining medical interventions, three focused specifically on the use of curcumin as an antioxidant in the treatment of OSF (<a href="./references#CD007156-bbs2-0121" title="Al-Maweri, SA. Efficacy of curcumin for management of oral submucous fibrosis: a systematic review of randomized clinical trials. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2019;127(4):300-8.">Al‐Maweri 2019a</a>; <a href="./references#CD007156-bbs2-0134" title="GuoJC , XieH , WuH , TongTJ . Efficacy of curcumin in the treatment of oral submucous fibrosis: a meta-analysis. West China Journal of Stomatology2021;39(2):195-202.">Guo 2021</a>; <a href="./references#CD007156-bbs2-0152" title="RaiA , KumarN , SharmaS , ParveenS , RasheedA . Turmeric in the management of oral submucous fibrosis: a systematic review and meta-analysis. Journal of Cancer Research and Therapeutics2021;17(2):327.">Rai 2021</a>). <a href="./references#CD007156-bbs2-0134" title="GuoJC , XieH , WuH , TongTJ . Efficacy of curcumin in the treatment of oral submucous fibrosis: a meta-analysis. West China Journal of Stomatology2021;39(2):195-202.">Guo 2021</a> determined through meta‐analysis that curcumin was not as effective as controls in improving mouth opening and did not reduce oral burning sensation. <a href="./references#CD007156-bbs2-0121" title="Al-Maweri, SA. Efficacy of curcumin for management of oral submucous fibrosis: a systematic review of randomized clinical trials. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2019;127(4):300-8.">Al‐Maweri 2019a</a> noted improvement in burning sensation following administration of curcumin, but also reported an inconclusive effect on mouth opening. <a href="./references#CD007156-bbs2-0152" title="RaiA , KumarN , SharmaS , ParveenS , RasheedA . Turmeric in the management of oral submucous fibrosis: a systematic review and meta-analysis. Journal of Cancer Research and Therapeutics2021;17(2):327.">Rai 2021</a> reported a small improvement in mouth opening and a reduction in burning sensation following the use of curcumin and turmeric in OSF treatment. <a href="./references#CD007156-bbs2-0133" title="GuoJ , XieH , WuH , LiangM . Efficacy of lycopene in the treatment of oral submucous fibrosis: a meta-analysis of randomized controlled trials. Journal of Evidence Based Dental Practice2020;20(4):101471.">Guo 2020b</a> systematically evaluated the antioxidant lycopene in treatment of OSF and found a modest improvement in mouth opening and no difference in alleviation of burning sensation compared with placebo with a short follow‐up period. <a href="./references#CD007156-bbs2-0135" title="GuptaN , KalaskarA , KalaskarR . Efficacy of lycopene in management of oral submucous fibrosis – a systematic review and meta-analysis. Journal of Oral Biology and Craniofacial Research2020;10(4):690-7.">Gupta 2020</a> also evaluated lycopene treatments and found no differences between lycopene and other treatments included in their review. One network meta‐analysis examined the effect of herbal derivatives on mouth opening and showed a small improvement with use of lycopene and aloe vera compared with placebo (<a href="./references#CD007156-bbs2-0153" title="Rajesh KashyapR , ShankerKR . Herbal derivatives in the management of mouth opening in oral submucous fibrosis – a network meta-analysis. Oral Diseases2021;27(7):1606-15.">Rajesh Kashyap 2021</a>). These reviews broadly corroborate our main finding that there may be some benefit to the use of antioxidants such as lycopene in the treatment of OSF. They mirrored our concerns about the reliability of the evidence due to the low number of RCTs and high risk of bias. These reviews did not identify any serious adverse effects of antioxidant interventions, but found limited reporting of adverse effects/events in the included studies. There are several putative adverse effects associated with specific antioxidants, including overdose, toxicity and drug interactions alongside those noted in our review. More rare instances of adverse effects have been reported, but the available evidence is mostly limited to case reports and series (<a href="./references#CD007156-bbs2-0147" title="MaxwellSR . Antioxidant vitamin supplements. Drug Safety1999;21(4):253-66.">Maxwell 1999</a>). To our knowledge, there have been no systematic safety evaluations of the antioxidant supplements used in the included studies. </p> <p><a href="./references#CD007156-bbs2-0146" title="LiuJ , ChenF , WeiZ , QiuM , LiZ , DanH , et al. Evaluating the efficacy of pentoxifylline in the treatment of oral submucous fibrosis: a meta-analysis. Oral Diseases2018;24(5):706-16.">Liu 2018</a> undertook a systematic review and meta‐analysis to evaluate the efficacy of pentoxifylline for treatment of OSF. They included three studies and found a modest improvement in interincisal distance. All studies had a low number of participants and there was considerable heterogeneity between them. The same authors also found that the effectiveness of the intervention was greatest at less than one month but did not persist longer term. Similarly, there was reduction in burning sensation that was sustained beyond three months of treatment. The adverse effects they reported corroborated our findings and included gastrointestinal disturbances and anxiety. These adverse effects were reported to be dose‐dependent. No serious adverse effects/events were reported. The authors concluded that pentoxifylline is an effective short‐ and long‐term treatment for OSF, although they noted a lack of accepted treatments for the condition. We consider that the conclusions about the long‐term effectiveness of pentoxifylline were not supported by the findings of their review, and we found that pentoxifylline does not appear to improve mouth opening at three to six months. </p> <p>One systematic review of aloe vera in the management of OSF combined six trials in meta‐analyses and reported an improvement in burning sensation with topical application of aloe vera at one and two months of follow‐up (<a href="./references#CD007156-bbs2-0122" title="Al-MaweriSA , AshrafS , LingamAS , AlqutaibiA , AbdulrabS , AlaizariN , et al. Aloe vera in treatment of oral submucous fibrosis: a systematic review and meta-analysis. Journal of Oral Pathology &amp; Medicine2019;48(2):99-107.">Al‐Maweri 2019b</a>). There was no difference between intervention and control after three months of follow‐up. There were no differences in mouth opening noted. The included trials had high heterogeneity; five were judged at high risk of bias, and one unclear. Similarly, we found no evidence to support the effectiveness of aloe vera for burning sensation or mouth opening in people with OSF. </p> <p>We did not find sufficient evidence to support or refute the effectiveness of hyaluronidase combined with corticosteroids in the management of OSF. This finding corroborates a systematic review and meta‐analysis by <a href="./references#CD007156-bbs2-0132" title="GuoJ , XieH , MaoS , LiangM , WuH . Efficacy of hyaluronidase combined with corticosteroids in treatment of oral submucous fibrosis: a meta-analysis of randomized controlled clinical trials. Journal of Oral Pathology &amp; Medicine2020;49(4):311-9.">Guo 2020a</a>, which combined six studies with 244 participants and also concluded that hyaluronidase with corticosteroids had no benefit over control drugs in improving mouth opening or alleviating burning sensation. However, it should be noted that the included studies had small numbers of participants and mostly made head‐to‐head comparisons with other drugs purported to manage the symptoms of OSF. There were no placebo‐controlled trials included. The one placebo‐controlled study we found showed no effectiveness of this intervention. </p> <p>One review of surgical interventions for OSF found a lack of controlled studies, small numbers of participants and short follow‐up periods (<a href="./references#CD007156-bbs2-0139" title="KamathVV . Surgical interventions in oral submucous fibrosis: a systematic analysis of the literature. Journal of Maxillofacial and Oral Surgery2015;14(3):521-31.">Kamath 2015</a>). There was often no standardisation of treatment protocols. Most studies were case reports or series and the authors concluded that the effectiveness of treatments could not be assessed, noting that surgeon preference was often the factor that determined treatment approach. This review echoes our findings; the small number of randomised surgical trials we identified had low numbers of participants and were at high risk of bias. </p> <p><a href="./references#CD007156-bbs2-0130" title="GondivkarSM , GadbailAR , SarodeSC , GondivkarRS , PatilS , GaikwadRN , et al. Clinical efficacy of mouth exercising devices in oral submucous fibrosis: a systematic review. Journal of Oral Biology and Craniofacial Research2020;10(4):315-20.">Gondivkar 2020</a> reviewed mouth exercising devices and identified five studies that examined five different devices with the goal of improving or maintaining mouth opening. Although one of these trials was an RCT and was included in our review (<a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a>), we judged it at high risk of bias due to blinding and allocation issues. The remaining devices were not evaluated by controlled trials and so, although the authors reported improvements in mouth opening for most of the devices, these findings should be interpreted cautiously. It is also of note that the studies had short follow‐up periods. It is unlikely that mouth stretching devices have any serious deleterious effects, but we agree with the authors' conclusions that more methodologically rigorous research is required. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD007156-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-FIG-01" target="_blank"><b></b></a></p> </div><img alt="original image" data-id="CD007156-fig-0001" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-FIG-01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-FIG-01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Risk of bias summary: review authors' judgements about each risk of bias item for each included study." data-id="CD007156-fig-0002" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Risk of bias summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD007156-fig-0003" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any intervention vs placebo (&lt; 3 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0004" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: Any intervention vs placebo (&lt; 3 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: Any intervention vs placebo (&lt; 3 months' follow‐up), Outcome 2: Burning sensation (VAS)" data-id="CD007156-fig-0005" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: Any intervention vs placebo (&lt; 3 months' follow‐up), Outcome 2: Burning sensation (VAS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0006" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 2: Burning sensation (VAS)" data-id="CD007156-fig-0007" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 2: Burning sensation (VAS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 3: Difficulty in speech" data-id="CD007156-fig-0008" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 3: Difficulty in speech </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 4: Difficulty in swallowing" data-id="CD007156-fig-0009" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 4: Difficulty in swallowing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 5: Difficulty in mouth opening" data-id="CD007156-fig-0010" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 5: Difficulty in mouth opening </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 6: Intolerance to spicy food" data-id="CD007156-fig-0011" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: Any intervention vs placebo (3–6 months' follow‐up), Outcome 6: Intolerance to spicy food </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Any intervention vs placebo (&gt; 6 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0012" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: Any intervention vs placebo (&gt; 6 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: Any intervention vs placebo (&gt; 6 months' follow‐up), Outcome 2: Burning sensation (VAS)" data-id="CD007156-fig-0013" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: Any intervention vs placebo (&gt; 6 months' follow‐up), Outcome 2: Burning sensation (VAS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Medicinal vs alternative medicinal (&lt; 3 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0014" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: Medicinal vs alternative medicinal (&lt; 3 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: Medicinal vs alternative medicinal (&lt; 3 months' follow‐up), Outcome 2: Burning sensation (VAS)" data-id="CD007156-fig-0015" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: Medicinal vs alternative medicinal (&lt; 3 months' follow‐up), Outcome 2: Burning sensation (VAS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-005.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Medicinal vs alternative medicinal (3–6 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0016" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-005.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-005.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5: Medicinal vs alternative medicinal (3–6 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-005.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-005.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Medicinal vs alternative medicinal (3–6 months' follow‐up), Outcome 2: Burning sensation (VAS)" data-id="CD007156-fig-0017" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-005.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-005.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5: Medicinal vs alternative medicinal (3–6 months' follow‐up), Outcome 2: Burning sensation (VAS) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-005.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-005.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Medicinal vs alternative medicinal (3–6 months' follow‐up), Outcome 3: Difficulty in speech" data-id="CD007156-fig-0018" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-005.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-005.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5: Medicinal vs alternative medicinal (3–6 months' follow‐up), Outcome 3: Difficulty in speech </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-005.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-005.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 5: Medicinal vs alternative medicinal (3–6 months' follow‐up), Outcome 4: Difficulty in swallowing" data-id="CD007156-fig-0019" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-005.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-005.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5: Medicinal vs alternative medicinal (3–6 months' follow‐up), Outcome 4: Difficulty in swallowing </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-005.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-006.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 6: Medicinal vs alternative medicinal (&gt; 6 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0020" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-006.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-006.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6: Medicinal vs alternative medicinal (&gt; 6 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-006.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-007.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 7: Surgery vs alternative surgery (&lt; 3 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0021" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-007.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-007.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7: Surgery vs alternative surgery (&lt; 3 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-007.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-008.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 8: Surgery vs alternative surgery (3–6 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0022" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-008.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-008.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8: Surgery vs alternative surgery (3–6 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-008.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-009.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 9: Surgery vs alternative surgery (&gt; 6 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0023" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-009.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-009.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9: Surgery vs alternative surgery (&gt; 6 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-009.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-010.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 10: Surgery + adjunctive medical intervention vs surgery (&lt; 3 months' follow‐up) , Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0024" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-010.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-010.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10: Surgery + adjunctive medical intervention vs surgery (&lt; 3 months' follow‐up) , Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-010.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-011.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 11: Physiotherapy + adjunctive medical intervention vs physiotherapy (&lt; 3 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0025" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-011.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-011.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11: Physiotherapy + adjunctive medical intervention vs physiotherapy (&lt; 3 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-011.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-012.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 12: Physiotherapy vs medical intervention (3–6 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0026" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-012.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-012.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12: Physiotherapy vs medical intervention (3–6 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-012.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-013.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 13: Physiotherapy vs alternative physiotherapy (3–6 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0027" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-013.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-013.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13: Physiotherapy vs alternative physiotherapy (3–6 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-013.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD007156-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/urn:x-wiley:14651858:media:CD007156:CD007156-CMP-014.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 14: Physiotherapy vs alternative physiotherapy (&gt; 6 months' follow‐up), Outcome 1: Interincisal distance (mm)" data-id="CD007156-fig-0028" src="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-014.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_t/tCD007156-CMP-014.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14: Physiotherapy vs alternative physiotherapy (&gt; 6 months' follow‐up), Outcome 1: Interincisal distance (mm) </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/media/CDSR/CD007156/image_n/nCD007156-CMP-014.01.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD007156-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Any intervention versus no active treatment or placebo for managing oral submucous fibrosis</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Any intervention versus no active treatment or placebo for managing oral submucous fibrosis</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient:</b> people with oral submucous fibrosis </p> <p><b>Setting:</b> any primary, secondary or tertiary care setting </p> <p><b>Intervention:</b> any medical, surgical or physical therapy </p> <p><b>Comparison:</b> placebo or no active treatment </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Follow‐up</b> </p> </th> <th align="center" class="headercell table-tint" colspan="2" rowspan="1" scope="col" valign="bottom"> <p><b>Illustrative comparative risks</b> </p> <p><b>(95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Number of participants (number of studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Certainty of the evidence (GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="bottom"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <th align="" class="headercell table-tint" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Assumed risk</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Corresponding risk</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Participant‐reported resumption of normal eating, chewing and speech</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>Outcome not reported by included studies</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Antioxidant vs placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo groups was 24.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 3.11 increase</b> (0.46 increase to 5.77 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>520 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊖⊖<br/><b>Low</b><sup>a,b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours antioxidant</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo groups was 25.56</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 8.83 increase</b> (8.22 increase to 9.45 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>620 (3)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊖<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours antioxidant</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo group was 30.37</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.41 reduction</b> (5.74 reduction to 2.92 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊖⊖<br/><b>Low</b><sup>c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Burning sensation</b> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo groups was 71.05</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 30.92 reduction</b> </p> <p>(31.57 reduction to 30.27 reduction)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>400 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊖<br/><b>Moderate</b><sup>b</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours antioxidant</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo groups was 72.74</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 70.82 reduction</b> </p> <p>(94.39 reduction to 47.25 reduction)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>500 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊖<br/><b>Moderate</b><sup>b,e</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours antioxidant</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo group was 42.3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 27.60 reduction</b> (36.21 reduction to 18.99 reduction) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊖<br/><b>Moderate</b><sup>d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours antioxidant</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Any</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 (minor) – flatulence and bloating</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>90 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Pentoxifylline vs placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo group was 23.10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.80 increase</b> (1.02 increase to 2.58 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊖⊖<br/><b>Low</b><sup>b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Favours pentoxifylline</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo groups was 24.66</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.15 reduction</b> (5.04 reduction to 4.74 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>136 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>a,b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Burning sensation</b> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo group was 33</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 7.00 reduction</b> (28.8 reduction to 42.8 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No adverse effects data reported</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Dexamethasone vs placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo group was 28.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 1.80 reduction</b> (6.30 reduction to 2.70 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo group was 29.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.1 reduction</b> (6.77 reduction to 2.57 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Burning sensation</b> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo group was 52.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 52.00 reduction</b> (62.04 reduction to 41.96 reduction) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo group was 46.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 46.00 reduction</b> (53.44 reduction to 38.56 reduction) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Any</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No adverse effects</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>25 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Vasodilator vs placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months' follow‐up</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo groups was 28.51</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 2.51 increase</b> (0.99 reduction to 6.01 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo groups was 29.30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 4.04 increase</b> (1.93 reduction to 10.02 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Burning sensation</b> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo groups was 64.75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 38.79 reduction</b> (52.06 reduction to 25.53 reduction) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>a,b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean VAS for placebo groups was 60.48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 51.02 reduction</b> (72.85 reduction to 29.20 reduction) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>a,b,d</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Any</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>14 (minor) – transient flushing and upper trunk warmness</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>85 (2)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Hydrocortisone + hyaluronidase vs placebo</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for placebo group was 33.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 4.88 reduction</b> (12.87 reduction to 3.11 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Burning sensation</b><sup>e</sup> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Any</p> </td> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>No adverse effects data reported</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="7" rowspan="1" scope="col" valign="top"> <p><b>Physiotherapy vs no active treatment</b> </p> </th> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><b>Interincisal distance</b> (mm) </p> <p>Increased value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&lt; 3 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>3–6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>Mean interincisal distance for control group was 33.13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>MD 0.50 increase</b> (7.72 reduction to 8.72 increase) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>24 (1)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊖⊖⊖<br/><b>Very low</b><sup>b,c</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>&gt; 6 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Burning sensation</b><sup>e</sup> </p> <p>(VAS, 0–100)</p> <p>Reduced value = improvement</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>No data for this outcome</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Adverse effects</b> </p> </td> <td align="" class="table-tint table-highlight" colspan="6" rowspan="1" valign="top"> <p>No adverse effects data reported</p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>CI:</b> confidence interval; <b>MD:</b> mean difference; <b>VAS:</b> visual analogue scale. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> </p> <p><b>High certainty:</b> we are very confident that the true effect lies close to that of the estimate of the effect. </p> <p><b>Moderate certainty:</b> we are moderately confident in the effect estimate: the true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different. </p> <p><b>Low certainty:</b> our confidence in the effect estimate is limited: the true effect may be substantially different from the estimate of the effect. </p> <p><b>Very low certainty:</b> we have very little confidence in the effect estimate: the true effect is likely to be substantially different from the estimate of effect. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>a</sup> Downgraded one level due to inconsistency (substantial heterogeneity).<br/><sup>b</sup> Downgraded one level due to serious concerns regarding risk of bias.<br/><sup>c</sup> Downgraded two levels due to very serious concerns regarding imprecision of effect estimate.<br/><sup>d</sup> Downgraded one level due to serious concerns regarding imprecision of effect estimate.<br/><sup>e</sup> As the heterogeneity between studies seemed to relate to magnitude rather than direction of effect, we did not downgrade for inconsistency. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Any intervention versus no active treatment or placebo for managing oral submucous fibrosis</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007156-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of the interventions</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Delivery method</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Details of intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Steroids (alone or in combination)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Betamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of betamethasone 4 mg/mL diluted in 1 mL of 2% xylocaine bilaterally biweekly for 6 months + habit cessation advice and oral prophylaxis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Submucosal injections of dexamethasone 2 mL (4 mg/mL) with 1 mL of 2% lignocaine with adrenaline (1:80,000), bilateral buccal mucosa, biweekly for 5 weeks with cheek massage and mouth opening physiotherapy 5 times daily and passive tongue spatula placement between teeth </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Combination hyaluronidase + dexamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Submucosal injections of a combination of dexamethasone 1 mL (4 mg/mL) and hyaluronidase (750 IU) diluted with 1 mL of 2% lignocaine with adrenaline (1:80,000) and 1 mL of water for injection. Bilateral buccal mucosa, biweekly for 5 weeks with cheek massage and mouth opening physiotherapy 5 times daily and passive tongue spatula placement between teeth </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hydrocortisone and hyaluronidase</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Injection of a combination of hydrocortisone acetate (1.5 mL of 25 mg/mL) and hyaluronidase (1500 IU) submucosally in retromolar trigone, soft palate and cheek bilaterally (half dose on each side). Performed every 15 days for 22 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Triamcinolone and hyaluronidase</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Injection of a combination of triamcinolone acetonide (10 mg/mL) and hyaluronidase (1500 IU) submucosally in retromolar trigone, soft palate and cheek bilaterally (half dose on each side). Performed every 15 days for 22 weeks </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0024" title="SinghM , NiranjanHS , MehrotraR , SharmaD , GuptaSC . Efficacy of hydrocortisone acetate/hyaluronidase vs triamcinolone acetonide/hyaluronidase in the treatment of oral submucous fibrosis. Indian Journal of Medical Research2010;131(5):665-9. ">Singh 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dexamethasone + hyaluronidase + 2% lidocaine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection 2 mL of dexamethasone with 1500 IU hyaluronidase mixed with 1 mL of 2% lidocaine with 1:80,000 adrenaline twice‐weekly for 6 weeks with mouth opening physiotherapy, cheek blowing exercises and habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hydrocortisone + hyaluronidase</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of hyaluronidase 1500 U and hydrocortisone 100 mg in sterile water, biweekly for 4 weeks with habit cessation advice and correction of any underlying anaemia with mebendazole 100 mg twice daily for 3 days and ferrous sulphate 200 mg and folic acid 5 mg for 4 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral lycopene + betamethasone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local + Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene 16 mg orally daily + 2 × 4 mg intralesional injection of betamethasone for 2 months with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Triamcinolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of triamcinolone 2 mg after 5 minutes of local anaesthetic cream, once per week for 20 weeks with habit cessation advice, and mouth stretching exercises 3 times per day for 15 minutes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Salvianolic acid + triamcinolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of both triamcinolone 2 mg and salvianolic acid B 4 mg after 5 minutes of local anaesthetic cream application, at weekly intervals for 20 weeks with habit cessation advice, and mouth stretching exercises 3 times per day for 15 minutes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dexamethasone + hyaluronidase</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of dexamethasone 4 mg/mL, hyaluronidase 1500 IU and 0.5 mL of 2% lidocaine with adrenaline administered weekly at multiple sites for 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prednisolone + salvia miltorrhiza</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly intralesional injections of 2 mL prednisolone acetate (25 g/L) and 1 mL lidocaine (20 g/L) and 2 mL of compound salvia miltorrhiza (1.5 g/mL) and 1 mL lidocaine (20 g/L) for 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Prednisolone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Weekly intralesional injection of prednisolone acetate (25 g/L) and 1 mL lidocaine (20 g/L) for 3 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0029" title="WuY , PengJ , QueG , XuC , YinX . Therapeutic effect of the combination of traditional Chinese medicine and western medicine on patients with oral submucous fibrosis. Zhong nan da xue xue bao. Yi xue ban [Journal of Central South University (Medical Sciences)]2010;35(4):358-64. [DOI: 10.3969/j.issn.1672-7347.2010.04.013]">Wu 2010</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hyaluronidase + hydrocortisone</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Injection of hyaluronidase 1500 U and hydrocortisone 100 mg in sterile water biweekly for 4 weeks with habit cessation advice, diet advice and correction of underlying anaemia with mebendazole 100 mg twice daily for 3 days and ferrous sulphate 200 mg and folic acid 5 mg for 4 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Surgery (alone or in combination)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery – extended nasolabial flaps</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral incision and release of buccal fibrous bands, coronoidectomy, reconstruction with extended nasolabial flaps, mouth opening physiotherapy for 6 months postoperatively </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery – nasolabial flap</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excision of fibrous bands, mouth opening using Heister's mouth gag (35–40 mm), coronoidectomy and reconstruction with nasolabial flap. Extraction of third molars, intensive physiotherapy using Heister's mouth gag 5–6 times daily for 20–30 minutes from day 3 postoperatively onwards </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery – abdominal dermal fat graft</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Excision of fibrous bands, mouth opening using Heister's mouth gag (35–40 mm), coronoidectomy, and reconstruction with abdominal dermal fat graft. Extraction of third molars, intensive physiotherapy using Heister's mouth gag 5–6 times daily for 20–30 minutes from day 3 postoperatively onwards </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0010" title="AnchilaS . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomised clinical trial. International Journal of Oral and Maxillofacial Surgery2022;51:e13-e14. KaniaJ , DhuvadJ , AnchliaS , BhattU , DholabhaiP , NakraniA . Abdominal dermal fat graft versus nasolabial flap in oral submucous fibrosis: a randomized clinical trial. Journal of Maxillofacial and Oral Surgery2022;25:1-9. ">Kania 2022</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery – buccal fat pad graft</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral incision and release of buccal fibrous bands, coronoidectomy, reconstruction with buccal fat pad graft, mouth opening physiotherapy for 6 months postoperatively </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0018" title="PatilSB , DurairajD , Suresh KumarG , KarthikeyanD , PradeepD . Comparison of extended nasolabial flap versus buccal fat pad graft in the surgical management of oral submucous fibrosis: a prospective pilot study. Journal of Maxillofacial &amp; Oral Surgery2017;16(3):312-21. ">Patil 2017</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery + placental extract</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral buccal mucosal fibrotomy and coronoidectomy repaired with buccal fat pad. Placental extract applied topically 4 hourly for 4 weeks with physiotherapy and oral hygiene instruction </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Bilateral buccal mucosal fibrotomy and coronoidectomy repaired with buccal fat pad with physiotherapy and oral hygiene instruction </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0027" title="ThakurG , ThomasS , BhargavaD , PandeyA . Does topical application of placental extract gel on postoperative fibrotomy wound improve mouth opening and wound healing in patients with oral submucous fibrosis?Journal of Oral and Maxillofacial Surgery2015;73(7):1439.e1-10. [DOI: 10.1016/j.joms.2015.03.020]">Thakur 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery + Heister jaw opener</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mouth opening physiotherapy using Heister jaw opener instrument between teeth 5–6 times daily for 6 months followed by another 12 months at reduced frequency alongside fibrous band incision with buccal fat pad repair, bilateral coronoidectomy, extraction of third molars, oral supplements of vitamin A 50,000 IU, vitamin B complex 200 mg, vitamin C 500 mg and beta‐carotene, along with topical application of triamcinolone acetonide 0.1% applied over the surgical area for ≥ 6 months postoperatively </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Surgery + wooden tongue depressors</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mouth opening physiotherapy using placement of wooden tongue depressors between teeth 5–6 times daily for 6 months, followed by another 12 months at reduced frequency. Fibrous band incision with buccal fat pad flap repair, bilateral coronoidectomy, and extraction of third molars. Oral supplements of vitamin A 50,000 IU, vitamin B complex 200 mg, vitamin C 500 mg and beta‐carotene, along with topical application of triamcinolone acetonide 0.1% applied over the surgical area for ≥ 6 months postoperatively </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0028" title="VadepallyAK , SalavadiRK , SinhaR . A comparative clinical study on physiotherapy outcomes with wooden tongue depressors versus Heister jaw opener in oral submucous fibrosis patients. Journal of Oral Biology &amp; Craniofacial Research2019;9(3):263-7. ">Vadepally 2019</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Physiotherapy (alone or in combination)</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Tongue spatulas placed passively between anterior teeth holding jaws open for 1 minute 5 times per session 5 times per day for 4 months with the addition of an additional spatula every 5th day with habit cessation advice, diet advice and correction of any underlying anaemia with mebendazole 100 mg twice daily for 3 days and ferrous sulphate 200 mg and folic acid 5 mg for 4 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0005" title="CoxS , ZoellnerH . Physiotherapeutic treatment improves oral opening in oral submucous fibrosis. Journal of Oral Pathology &amp; Medicine2009;38(2):220-6. [DOI: 10.1111/j.1600-0714.2008.00696.x]">Cox 2009</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physiotherapy + ultrasound therapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Ultrasound therapy for 7 minutes over 1 week (intervals unknown) + jaw opening exercises – maximal opening for 5 seconds, lateral deviations and protrusion of mandible repeated 10 times </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Physiotherapy</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Jaw opening exercises – maintain maximal mouth opening for 5 seconds, lateral deviations and protrusion of mandible, repeated 10 times for 1 week </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0006" title="DaniVB , PatelSH . The effectiveness of therapeutic ultrasound in patients with oral submucosal fibrosis. Indian Journal of Cancer2018;55(3):248-50. [DOI: 10.4103/ijc.IJC_611_17]">Dani 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Pentoxifylline</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral pentoxifylline 400 mg twice daily for 30 days then 3 times daily for 6 months + habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0012" title="MehrotraR , SinghHP , GuptaSC , SinghM , JainS . Pentoxifylline therapy in the management of oral submucous fibrosis. Asian Pacific Journal of Cancer Prevention2011;12(4):971-4. ">Mehrotra 2011</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oral pentoxifylline 2 × 400 mg tablets daily for 30 days then 3 × 400 mg tablets daily for 6 months with 1 multivitamin tablet at night, local heat therapy and mouth opening exercises </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0023" title="RajendranR , RaniV , ShaikhS . Pentoxifylline therapy: a new adjunct in the treatment of oral submucous fibrosis. Indian Journal of Dental Research2006;17(4):190-8. ">Rajendran 2006</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × pentoxifylline 400 mg tablets twice daily for 3 months with habit cessation advice</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × pentoxifylline tablets daily for 15 days, followed by 3 tablets daily for 3.5 months </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0021" title="PrabhuN , RaoSS , KotrashettiSM , BaligaSD , HallikerimathSR , AngadiPV , et al. Pentoxifylline in patients with oral submucous fibrosis – a randomized clinical trial. Journal of Maxillofacial &amp; Oral Surgery2015;14(1):81-9. ">Prabhu 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline 400 mg orally twice daily for 3 months with daily mouth opening exercises</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Aloe vera</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera 5 mg gel applied topically to buccal mucosa bilaterally 3 times per day for 3 months with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera 5 mg gel topically 3 times daily for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Aloe vera gel applied topically to lesions 3 times daily for 3 months with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Lycopene</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene 2 mg capsules twice daily for 6 months with habit cessation advice and oral prophylaxis </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0007" title="GoelS , AhmedJ . A comparative study on efficacy of different treatment modalities of oral submucous fibrosis evaluated by clinical staging in population of Southern Rajasthan. Journal of Cancer Research and Therapeutics2015;11(1):113-8. ">Goel 2015</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene 16 mg orally daily for 2 months with habit cessation advice</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0011" title="KumarA , BagewadiA , KeluskarV , SinghM . Efficacy of lycopene in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontology2007;103(2):207-13. ">Kumar 2007</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Lycopene</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 × lycopene 8 mg capsule twice daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Mixed antioxidants</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mixed antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Antioxidant capsules (beta‐carotene 5 mg; mixed carotenoids 5 mg; vitamin E 25 mg; chromium 200 μg; zinc 7.5 mg; manganese 1.5 mg; copper 1 mg; selenium 150 μg; vitamin C 100 mg) orally twice daily for 3 months with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0026" title="SudarshanR , AnnigeriRG , Sree VijayabalaG . Aloe vera in the treatment for oral submucous fibrosis – a preliminary study. Journal of Oral Pathology &amp; Medicine2012;41(10):755-61. [DOI: 10.1111/j.1600-0714.2012.01168.x]">Sudarshan 2012</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Mixed antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 tablet of Turmix (combination curcumin and piperine 300 mg) twice daily for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0020" title="PiyushP , MahajanA , SinghK , GhoshS , GuptaS . Comparison of therapeutic response of lycopene and curcumin in oral submucous fibrosis: a randomized controlled trial. Oral Diseases2018;25(1):73-9. ">Piyush 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Mixed antioxidants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2 tablets of Turmix (Curcumin longa 300 mg, piperine 5 mg) orally for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007156-bbs2-0030" title="YadavM , AravindaK , SaxenaVS , SrinivasK , RatnakarP , GuptaJ , et al. Comparison of curcumin with intralesional steroid injections in oral submucous fibrosis – a randomized, open-label interventional study. Journal of Oral Biology &amp; Craniofacial Research2014;4(3):169-73. ">Yadav 2014</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Oxitard</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oxitard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 Oxitard capsules twice daily for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>; <a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Oxitard</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 Oxitard capsules twice daily for 3 months with habit cessation advice</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Spirulina</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina 250 mg orally twice daily for 3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina 500 mg orally twice daily for 3 months with daily mouth opening exercises</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0013" title="MulkBS , DeshpandeP , VelpulaN , ChappidiV , ChintamaneniRL , GoyalS . Spirulina and pentoxyfilline – a novel approach for treatment of oral submucous fibrosis. Journal of Clinical and Diagnostic Research2013;7(12):3048-50. [DOI: 10.7860/JCDR/2013/7085.3849]">Mulk 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina 500 mg twice daily for 3 months with habit cessation advice</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0019" title="PatilSR , MaragathavalliG , RameshDN , MunishekarMS , RaoKA , AlamMK . Comparative efficacy of newer antioxidants spirulina and Oxitard for the treatment of oral submucous fibrosis. International Medical Journal2019;26(2):135-8. ">Patil 2019</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="4" rowspan="1" valign="top"> <p><b>Other</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Curcumin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 curcumin 500 mg capsules daily + habit cessation for 6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Isoxsuprine</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Isoxsuprine 10 mg orally 4 times per day for 6 weeks, mouth opening physiotherapy and cheek blowing exercises, habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0004" title="BhadageCJ , UmarjiHR , ShahK , ValimaaH . Vasodilator isoxsuprine alleviates symptoms of oral submucous fibrosis. Clinical Oral Investigations2013;17(5):1375-82. [DOI: 10.1007/s00784-012-0824-z]">Bhadage 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Xantitol nicotinate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of xantitol nicotinate biweekly for 4 months with mouth opening physiotherapy </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0025" title="SinghU . Efficacy and safety of intralesional xantinol nicotinate in the treatment of various stages of oral submucous fibrosis. Journal of Clinical and Diagnostic Research JCDR2016;10(10):ZC34-7. ">Singh 2016</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Salvianolic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Local</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intralesional injection of salvianolic acid B 4 mg after 5 minutes of local anaesthetic cream application at weekly intervals for 20 weeks with habit cessation advice, and mouth stretching exercises 3 times per day for 15 minutes </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0008" title="JiangXW , ZhangY , YangSK , ZhangH , LuK , SunGL . Efficacy of salvianolic acid B combined with triamcinolone acetonide in the treatment of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2013;115(3):339-44. [DOI: 10.1016/j.oooo.2012.10.006]">Jiang 2013</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Salvianolic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1 capsule salvianolic acid antioxidant twice daily for 6 weeks with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Levisamole</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Levisamole 50 mg tablet orally 3 times daily for 3 consecutive days per week for 3 alternate weeks with habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Levisamole + salvianolic acid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Systemic</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Levisamole 50 mg tablet orally 3 times daily for 3 consecutive days per week for 3 alternate weeks with 1 capsule salvianolic acid twice daily for 6 weeks + habit cessation advice </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0009" title="JirgeV , ShashikanthMC , AliIM , AnshumaleeN . Levamisole and antioxidants in the management of oral submucous fibrosis: a comparative study. Journal of Indian Academy of Oral Medicine and Radiology2008;20(4):135. ">Jirge 2008</a> </p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Characteristics of the interventions</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007156-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Participant‐reported outcome measures</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Follow‐up</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcome (s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention – outcome frequency (%) (baseline – endpoint)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Control – outcome frequency (%) (baseline – endpoint)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comment</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p><a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>100 (50 per group)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Curcumin</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="3" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in mouth opening</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intolerance to spicy food</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Oxitard capsules</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Topical aloe vera gel</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>59</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pentoxifylline 400 mg twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Multivitamin (placebo)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>43</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intergroup differences not assessed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intergroup differences not assessed</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p><a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>2 Oxitard capsules twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>64</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P &lt; 0.001)</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Participant‐reported outcome measures</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007156-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pain</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparator(s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Follow‐up</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcomes (s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention A – outcome</b> </p> <p><b>mean difference (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention B – outcome</b> </p> <p><b>mean (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison</b> </p> <p><b>– outcome mean difference (SD)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comment</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0001" title="Alora VeeduR , BalanA , SankarSP . A randomized double-blind, multiple-arm trial comparing the efficacy of submucosal injections of hyaluronidase, dexamethasone, and combination of dexamethasone and hyaluronidase in the management of oral submucous fibrosis. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology2015;120(5):588-93.e1. [DOI: 10.1016/j.oooo.2015.07.003]">Alora Veedu 2015</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Hyaluronidase submucosal injection</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Dexamethasone submucosal injection</p> <p>Hyaluronidase + dexamethasone submucosal injections</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain while opening mouth (VAS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.00 (1.69)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.33 (0.72)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.93 (2.15)<sup>a</sup> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difference between groups (P = 0.035)</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 × 500 mg curcumin capsules once daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>6 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain (VAS)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3.16 (4.23)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Unclear how pain was differentiated from burning sensation in this study</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Study ID</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparator(s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Follow‐up</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Outcomes (s)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Intervention A – outcome</b> </p> <p><b>frequency (%) (baseline – endpoint)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>—</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comparison – outcome</b> </p> <p><b>frequency (%) (baseline –endpoint)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="bottom"> <p><b>Comment</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pentoxifylline 400 mg twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Multivitamin (placebo)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain associated with lesion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>75</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 Oxitard capsules twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical aloe vera gel 5 mg 3 times daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain associated with lesion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>48</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 Oxitard capsules twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>3 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain associated with lesion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>79</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>62</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><a href="./references#CD007156-bbs2-0017" title="PatilS , Al-ZareaBK , MaheshwariS , SahuR . Comparative evaluation of natural antioxidants spirulina and aloe vera for the treatment of oral submucous fibrosis. Journal of Oral Biology &amp; Craniofacial Research2015;5(1):11-5. ">Patil 2015b</a> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>42</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Spirulina 250 mg oral twice daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Topical aloe vera gel 5 mg 3 times daily</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Pain associated with lesion</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>—</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Intergroup differences not measured</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="10"> <div class="table-footnote"> <p><sup>a</sup> change from baseline reported<br/>SD: standard deviation; VAS: visual analogue scale. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Pain</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD007156-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Additional outcome measure – difficulty in speech, swallowing and mouth opening</span></div> <tbody> <tr> <th align="" class="headercell" colspan="2" rowspan="1" scope="col" valign=""> <p><b>Intervention versus placebo comparisons</b> </p> </th> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 trials with 226 participants recorded 'difficulty in speech' using a VAS, but then reported this as a dichotomous outcome (presence/absence) (<a href="./references#CD007156-fig-0008" title="">Analysis 2.3</a>). </p> <p><a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a> included 120 participants and compared an antioxidant (Oxitard) with placebo. There was a reduction in the frequency of 'difficulty in speech' (OR 0.51, 95% CI 0.21 to 1.22). In the placebo group, there were 17 participants reporting 'difficulty in speech' compared with 10 participants in the intervention group. We judged this trial at unclear risk of bias. </p> <p><a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> included 106 participants and compared pentoxifylline with placebo. There was a reduction in the frequency of 'difficulty in speech' (OR 0.20, 95% CI 0.08 to 0.48). In the placebo group, there were 27 participants reporting 'difficulty in speech' compared with 9 participants in the intervention group. We judged this trial at high risk of bias. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>2 trials with 220 participants compared antioxidants (curcumin and Oxitard) with placebo (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>; <a href="./references#CD007156-bbs2-0016" title="PatilS , SantoshBS , MaheshwariS , DeoghareA , ChhuganiS , RajeshPR . Efficacy of Oxitard capsules in the treatment of oral submucous fibrosis. Journal of Cancer Research and Therapeutics2015;11(2):291-4. ">Patil 2015a</a>). There was an overall reduction in the frequency of 'difficulty in swallowing' (OR 0.24, 95% CI 0.10 to 0.60; <a href="./references#CD007156-fig-0009" title="">Analysis 2.4</a>). In the placebo groups, there were 24 participants reporting 'difficulty in swallowing' compared with 7 participants in the intervention groups. </p> <p><a href="./references#CD007156-bbs2-0014" title="PatilS , MaheshwariS . Efficacy of pentoxifylline in the management of oral submucous fibrosis. Journal of Orofacial Sciences2014;6(2):94-8. [DOI: 10.4103/0975-8844.143048]">Patil 2014a</a> included 106 participants and compared pentoxifylline with placebo. There was a reduction in the frequency of 'difficulty in swallowing' (OR 0.42, 95% CI 0.19 to 0.92). In the placebo group, there were 27 participants reporting 'difficulty in swallowing' compared with 16 participants in the intervention group. We judged this trial at high risk of bias. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in mouth opening</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 trial with 100 participants compared an antioxidant to placebo (curcumin) (<a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a>). There was a reduction in the frequency of participants reporting 'difficulty in mouth opening' (OR 0.00, 95% CI 0.00 to 0.02; <a href="./references#CD007156-fig-0010" title="">Analysis 2.5</a>). In the placebo group, there were 47 participants reporting 'difficulty in mouth opening' compared with 2 in the intervention group. We judged this trial at unclear risk of bias. <a href="./references#CD007156-bbs2-0002" title="AraSA , MuddaJ , LingappaA , RaoP , ZakaullahS . Efficacy of curcumin in oral submucous fibrosis – a randomized controlled clinical trial. International Journal of Pharmaceutical Sciences and Research2018;9(12):5277-86. ">Ara 2018</a> reported a reduction in the frequency of participants with 'intolerance to spicy food' (OR 0.02, 95% CI 0.00 to 0.43). In the placebo group, there were 14 participants reporting 'intolerance to spicy food' compared with 0 in the intervention group. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="2" rowspan="1" valign=""> <p><b>Head‐to‐head comparisons</b> </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in speech</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1 study with 120 participants compared Oxitard capsules with aloe vera gel (<a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a>). There was a decrease in the frequency of participants reporting 'difficulty in speech' in favour of Oxitard (OR 0.32, 95% CI 0.14 to 0.76; <a href="./references#CD007156-fig-0018" title="">Analysis 5.3</a>). There were 23 participants reporting 'difficulty in speech' in the aloe vera group compared with 10 participants in the Oxitard group at 3–6 months' follow‐up. This study was at high risk of bias. </p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Difficulty in swallowing</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><a href="./references#CD007156-bbs2-0015" title="PatilS , HalgattiV , MaheshwariS , SantoshBS . Comparative study of the efficacy of herbal antioxidants Oxitard and aloe vera in the treatment of oral submucous fibrosis. Journal of Clinical &amp; Experimental Dentistry2014;6(3):e265-70. ">Patil 2014b</a> reported a decrease in the frequency of participants reporting 'difficulty in swallowing' in favour of Oxitard (OR 0.17, 95% CI 0.07 to 0.44; <a href="./references#CD007156-fig-0019" title="">Analysis 5.4</a>). There were 26 participants reporting 'difficulty in swallowing' in the aloe vera group compared with 7 participants in the Oxitard group at 3–6 months' follow‐up. This study was at high risk of bias. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="2"> <div class="table-footnote"> <p>CI: confidence interval; OR: odds ratio; VAS: visual analogue scale.</p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Additional outcome measure – difficulty in speech, swallowing and mouth opening</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/full#CD007156-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any intervention vs placebo (&lt; 3 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.1 Antioxidants vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>520</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.11 [0.46, 5.77]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.2 Pentoxifylline vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.80 [1.02, 2.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.3 Vasodilators vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.51 [‐0.99, 6.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1.4 Intralesional dexamethasone injections vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.80 [‐6.30, 2.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 Burning sensation (VAS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.1 Antioxidant vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>400</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐30.92 [‐31.57, ‐30.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.2 Vasodilator vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐38.79 [‐52.06, ‐25.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2.3 Dexamethasone vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐52.00 [‐62.04, ‐41.96]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Any intervention vs placebo (&lt; 3 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any intervention vs placebo (3–6 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.1 Antioxidant vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>620</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.83 [8.22, 9.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.2 Pentoxifylline vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>136</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐5.04, 4.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.3 Dexamethasone vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.10 [‐6.77, 2.57]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.4 Vasodilator vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.04 [‐1.93, 10.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.5 Hydrocortisone + hyaluronidase vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.88 [‐12.87, 3.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1.6 Physiotherapy vs control</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐7.72, 8.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 Burning sensation (VAS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.1 Antioxidant vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>500</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐70.82 [‐94.39, ‐47.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.2 Pentoxifylline vs usual care</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>7.00 [‐28.79, 42.79]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.3 Vasodilator vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐51.02 [‐72.85, ‐29.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2.4 Dexamethasone vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐46.00 [‐53.44, ‐38.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 Difficulty in speech <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.1 Pentoxifylline vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.08, 0.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.3.2 Antioxidant vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.21, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 Difficulty in swallowing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.1 Pentoxifylline vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>106</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.19, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.4.2 Antioxidant vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.24 [0.10, 0.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 Difficulty in mouth opening <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.5.1 Antioxidant vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [0.00, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 Intolerance to spicy food <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.6.1 Antioxidant vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.02 [0.00, 0.43]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Any intervention vs placebo (3–6 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Any intervention vs placebo (&gt; 6 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1.1 Curcumin or lycopene vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.41 [‐5.74, 2.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 Burning sensation (VAS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 Antioxidant vs placebo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>90</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐27.60 [‐36.21, ‐18.99]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Any intervention vs placebo (&gt; 6 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Medicinal vs alternative medicinal (&lt; 3 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.1 Steroid vs alternative (medicinal treatment)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>128</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.64 [‐2.16, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.2 Steroid vs alternative (steroid + adjunct)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.03 [‐2.48, 2.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.3 Levamisole vs alternative (antioxidant)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐7.18, 5.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.4 Topical curcumin gel vs alternative (topical aloe vera gel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.64 [‐3.91, 2.63]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.5 Spirulina vs alternative (oxitard)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.60 [‐3.82, ‐1.38]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1.6 Oxitard capsules vs alternative (aloe vera gel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.40 [8.52, 10.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Burning sensation (VAS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.1 Steroid vs alternative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>58</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.06 [‐10.64, 10.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.2 Steroid vs alternative (steroid + adjunct)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐10.37, 8.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.3 Levamisole vs alternative (antioxidant)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐9.10 [‐16.23, ‐1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2.4 Topical curcumin gel vs alternative (topical aloe vera gel)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>16.00 [7.21, 24.79]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Medicinal vs alternative medicinal (&lt; 3 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Medicinal vs alternative medicinal (3–6 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.1 Steroid vs alternative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.57 [‐2.34, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.2 Steroid vs alternative (steroid + adjunct)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>148</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.85 [‐3.31, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.3 Pentoxifylline vs alternative (spirulina)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐8.00 [‐14.47, ‐1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1.4 Levamisole vs alternative (antioxidant)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.00 [‐7.18, 5.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.2 Burning sensation (VAS) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.1 Steroid vs alternative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>98</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.61 [‐4.52, 21.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.2 Steroid vs alternative (steroid + adjunct)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐16.30 [‐28.15, ‐4.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.3 Pentoxifylline vs alternative (spirulina)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.50 [‐6.60, 7.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.2.4 Levamisole vs alternative (antioxidant)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.00 [‐13.56, ‐0.44]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.3 Difficulty in speech <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.3.1 Antioxidant vs topical aloe vera</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.14, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5.4 Difficulty in swallowing <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.4.1 Antioxidant vs topical aloe vera</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Odds Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.17 [0.07, 0.44]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Medicinal vs alternative medicinal (3–6 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Medicinal vs alternative medicinal (&gt; 6 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.1 Steroids vs alternative</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.60 [‐3.76, 2.56]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1.2 Steroid vs alternative (steroid + adjunct)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.38 [‐5.64, 0.88]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Medicinal vs alternative medicinal (&gt; 6 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Surgery vs alternative surgery (&lt; 3 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.1 Buccal fat pad vs alternative (extended nasolabial flap)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐7.25 [‐14.19, ‐0.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>7.1.2 Abdominal dermal fat graft vs alternative (nasolabial flap)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.60 [‐5.17, ‐2.03]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Surgery vs alternative surgery (&lt; 3 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Surgery vs alternative surgery (3–6 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.1 Abdominal dermal fat graft vs alternative (nasolabial flap)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>30</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐14.87 [‐19.93, ‐9.81]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>8.1.2 Extended nasolabial flap vs alternative (buccal fat pad)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐6.00 [‐23.36, 11.36]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Surgery vs alternative surgery (3–6 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Surgery vs alternative surgery (&gt; 6 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Surgery vs alternative surgery (&gt; 6 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Surgery + adjunctive medical intervention vs surgery (&lt; 3 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">10.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Surgery + adjunctive medical intervention vs surgery (&lt; 3 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Physiotherapy + adjunctive medical intervention vs physiotherapy (&lt; 3 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">11.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>11.1.1 Ultrasound + jaw opening exercises vs jaw opening exercises</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐3.70 [‐11.53, 4.13]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Physiotherapy + adjunctive medical intervention vs physiotherapy (&lt; 3 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Physiotherapy vs medical intervention (3–6 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">12.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>12.1.1 Tongue depressor stretches vs Local injection hyaluronidase + steroid</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>20</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.38 [‐2.24, 13.00]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Physiotherapy vs medical intervention (3–6 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Physiotherapy vs alternative physiotherapy (3–6 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">13.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>13.1.1 Heister jaw opener vs wooden tongue depressors</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.28, 1.56]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Physiotherapy vs alternative physiotherapy (3–6 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD007156-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Physiotherapy vs alternative physiotherapy (&gt; 6 months' follow‐up)</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">14.1 Interincisal distance (mm) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>14.1.1 Heister jaw opener vs wooden tongue depressors</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.01, 1.19]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Physiotherapy vs alternative physiotherapy (&gt; 6 months' follow‐up)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD007156.pub3/references#CD007156-tbl-0019">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD007156.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="es#CD007156-note-0018">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD007156-note-0015">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD007156-note-0016">Français</a> </li> <li class="section-language"> <a class="" href="hi#CD007156-note-0009">हिंदी</a> </li> <li class="section-language"> <a class="" href="ja#CD007156-note-0014">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD007156-note-0012">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD007156-note-0013">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD007156-note-0017">Polski</a> </li> <li class="section-language"> <a class="" href="th#CD007156-note-0011">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD007156-note-0008">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD007156-note-0010">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007156\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007156\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007156\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD007156\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD007156\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=qy4lqFNF&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007156.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD007156.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD007156.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD007156.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD007156.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728915628"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007156.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728915632"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD007156.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ed0209a989368',t:'MTc0MDcyODkxNi4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 